Patient and physician views of self-testing: blood glucose monitoring by Iqbal, Sana
















A Thesis Submitted in Partial Fulfillment 
 of the Requirements for the Degree of 
 




The Faculty of Health Sciences 
 
University of Ontario Institute of Technology 
 
 
©Sana Iqbal, 2017  













First and foremost, I would like to thank my research supervisor, Dr. Brenda 
Gamble. You have guided my academic journey with constant positivity, words of 
encouragement and support. Your direction and mentorship have been invaluable to me 
over the last two years.  
Thank you to Dr. Gail Lindsay for introducing me to qualitative research and for 
helping me to frame my perspectives. Your guidance, especially in the Qualitative 
Research Works-in-Progress workshops were greatly appreciated.  
I would like to extend a special thanks to Dr. Hilde Zitzelsberger. Thank you for 
inspiring my research within the qualitative realm. Your expertise and shared enthusiasm 
in my area of research has been instrumental in shaping my study. I also thank you for 
your time, patience and kindness in helping me to acknowledge who I am as a qualitative 
researcher.     
I would also like to extend a special thanks to Dr. Milly Ryan-Harshman. I am so 
appreciative of your passion in academic writing, as I share the same zeal for writing as 
you do. Thank you for so thoroughly editing my work and encouraging me to become a 
more capable writer.  
I am especially grateful to Dr. Edward Osborne and Dr. Mike Ward. Your mutual 
passion for academia and desire to improve patient care turned this research endeavour 
into a reality. I would not have been able to conduct this research without your support.  
  I would like to acknowledge the staff within the offices of the Bowmanville 
Health Centre and Newcastle Village Medical Associates for their roles in the research 
study. 
I would like to extend a sincere thank you to all of my research participants. 
Thank you for sharing your time and letting your voices be heard. I am deeply grateful 
and appreciative that you shared your experiences for this research endeavour.      
Finally, I would like to thank my colleagues and friends, and most importantly, 
my family. Your unwavering support, patience and understanding through this entire 
process has helped me to achieve all of my goals.         






I would like to dedicate this thesis to my loving mother.  
 
You took great interest in my work, and encouraged me every step of the way. 
Thank you for your support and endless motivation.  
 
You are the epitome of selflessness. Your heart exudes an overwhelming amount 
of unconditional love and affection, and I aspire to one day be as strong and as resilient as 
you are.   
 
Ami Jaan, you are my greatest blessing!   





Medical laboratories deliver an invaluable healthcare service by providing 
laboratory results to aid in the diagnosis and monitoring of disease states. Point-of-care 
testing (POCT), a sub-sector of medical laboratory services, is completed at the patient’s 
bedside with the goal of providing clinical laboratory results in a very short time frame to 
assist caregivers in clinical decision making (Ehrmeyer & Laessig, 2007). The 
technology within this sector of laboratory sciences continues to grow rapidly, making 
Point-of-Care (POC) tests more accessible for use in a variety of settings, essentially 
decentralizing laboratory testing. This represents an important shift in healthcare culture 
as it provides healthcare practitioners and patients alike, the opportunity to perform an 
ever-growing number of laboratory tests, anywhere and at any time. Through the use of 
semi-structured interview questions, this qualitative research project utilized a case study 
informed methodology to understand the role of patient autonomy in self-testing (ST) and 
the function of accountability as it relates to POCT, when testing occurs in an 
unregulated environment. Findings suggest that ST and self-care behaviours in diabetes 
that are autonomously initiated result in positive outcomes, as patients are more likely to 
be active participants in their own healthcare. The principle of patient autonomy was 
highlighted in the research by the need to build strong patient/physician relationships in 
order to facilitate dialogue that promotes informed decision-making, an important aspect 
of patient care. Patients also felt that participating in ST provided them with a greater 
sense of control over their health, and that an increased frequency of ST could be seen 
only in a positive manner, regardless of which self-test was being performed. Conversely, 
the cost and the possibility of encountering difficulties in the interpretation and 
troubleshooting of self-test results were seen as negative aspects of ST.  Through this 
research endeavour, the necessity for greater measures of accountability were also made 
evident, as patients and physicians discussed how self-testing could impact patient care. 
Short-term and long-term goals are provided as recommendations to strengthen 
accountability in POCT within unregulated environments. 
 
Key words: accountability, patient autonomy, safety, self-monitoring blood glucose, self-
testing 
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Chapter 1 – Introduction 
1.0.  Background 
Clinical laboratory testing is an invaluable tool to many healthcare providers. 
Laboratory test results can be used to confirm or exclude health conditions, classify and 
monitor disease states and/or guide treatment options (Badrick, 2013). In Ontario, the 
laboratory medicine sector is highly regulated. In order to provide services, medical 
laboratories must be compliant with a number of rigorous accreditation standards1 and 
must be accountable to multiple healthcare regulatory agencies. Accountability2 in 
Ontario laboratories is well established in ambulatory and acute healthcare settings. 
Within the healthcare services sector particularly, Deber (2014) identified three 
dimensions of accountability: fiscal accountability, clinical accountability and 
accountability to the public. Three key organizations responsible for ensuring that 
laboratories and laboratory personnel are held accountable for their actions are 
Accreditation Canada (AC), The College of Medical Laboratory Technologists of Ontario 
(CMLTO) and the Institute for Quality Management in Healthcare (IQMH). Although 
these organizations are all independent from one another, they share a common goal: to 
ensure that patient safety is always held in the highest regard. The CMLTO, AC and 
IQMH each outline a set of quality standards which are provided to help direct healthcare 
institutions in strengthening their accountability and managing risk reduction. This 
ensures that laboratory services provide highly accurate and reliable test results to 
physicians, in order to guide therapeutic health interventions and to aid in disease 
diagnosis.  
A rapidly growing sub-sector of laboratory services is Point-of-Care Testing 
(POCT). It is estimated that central laboratory testing is only growing at a rate of 6-7% 
annually, whereas POCT is growing at a rate of up to 30% per year, depending on the 
testing area (College of American Pathologists, 2012). POCT is completed at the 
patient’s bedside with the goal of providing clinical laboratory results in a very short time 
frame to assist caregivers in clinical decision-making (Ehrmeyer & Laessig, 2007). Three 
                                                 
1 Some accreditation standards are mandatory, whilst subscription to other accreditation standards remain 
voluntary 
2 Accountability: A process in which one takes responsibility for their actions (Emanuel & Emanuel, 1996). 




levels of complexity exist for POCT: “simple procedures such as glucose testing, 
moderate-complexity procedures (including provider performed microscopy procedures), 
or high-complexity procedures such as influenza testing” (AC, 2013). Although the 
testing systems themselves may be simple and easy to use, it does not mean there is no 
chance for erroneous results. Errors may take place anywhere through the testing process 
if manufacturer’s instructions are not followed, or if the individuals performing the 
testing are not familiar with the test/testing platform. These errors may adversely impact 
a patient’s care (CDC, 2015). 
In ambulatory and acute care settings, laboratory services are responsible for 
managing all aspects of POCT, as well as ensuring that all accreditation requirements are 
being satisfied. Quality assurance3 programs in these institutions facilitate standard 
operating procedures4 to ensure that all accreditation requirements are met and followed. 
Such accreditation standards transparently provide a system whereby methods to address 
accountability are well established for laboratories, their staff, other healthcare providers 
and the general public. This is especially the case when organizations such as the 
CMLTO, AC and IQMH work in tandem with healthcare facilities to achieve the highest 
level of patient centered care.  
Of note however, the area of POCT continues to develop and expand outside of 
conventional healthcare settings. With improved technology and better appreciation of 
the diagnostic tools that laboratories can offer, POCT has widened the breadth of tests 
available at the point-of-care5 (POC). This makes POC tests more mainstream and 
largely accessible to consumers. Dilts (1998) explained that the evolution of home testing 
kits would make it commonplace to purchase routine hematology, chemistry and 
coagulation tests without prescriptions at retail stores. As of 2013, North American 
countries held the largest share of the global POC diagnostics market, followed by the 
Asia-Pacific region6, Europe and the rest of the world (Markets and Markets, 2014). With 
                                                 
3 Quality Assurance: A set of principles and procedures that guide the laboratory in achieving and 
maintaining a high level of accuracy and proficiency throughout the testing process (CDC, 2014). 
4 Standard Operating Procedure: a written set of instructions which describes how to perform a task safely 
and correctly 
5 Point-of-Care: at or near the patient 
6 Asia-Pacific Region: Japan, China, India, and the Rest of Asia-Pacific (Markets and Markets, 2014) 




rate of self-testing (ST) skyrocketing, it is anticipated that ST will contribute to an 
estimated global market of $27.5 billion by the year 2018 (Markets and Markets, 2016). 
1.1.  The Diabetes Epidemic 
Testing blood sugar levels at the POC has an estimated market of $8 billion 
dollars worldwide (Rajan & Glorikian, 2009). The diabetes epidemic is currently a strong 
driver of the POC blood glucose market (Markets and Markets, 2014), and it is 
anticipated that testing blood glucose levels will continue to represent the majority of the 
POC market for the foreseeable future (Rajan & Glorikian, 2009). As a result, diabetic 
patients using glucometers represents the most homogenous population of end-users for 
POC tests. Glucometers were amongst the first devices to be introduced to the POC 
market in the late 1980s, as a method to support diabetic patients in managing their blood 
glucose levels (St John & Price, 2014). Over a period of years, every new generation of 
glucometers became more improved than the previous, and eventually glucometers began 
to find their way into hospital-based settings. These devices have been shown to improve 
patient outcomes whilst reducing hospital complications and mortality rates in diabetics 
and non-diabetics alike, by contributing to improved disease management and tighter 
glycemic control (Lewandrowski, 2009). Glucometers are now amongst the most 
common POC devices on the market due largely in part to the number of diabetic patients 
who are required to monitor their blood glucose levels (St John & Price, 2014). 
1.2.  Focus and Impact of Research Study 
Lifestyle choices can be important contributors impacting health conditions. More 
recently, government and healthcare agencies have come to acknowledge the role of 
lifestyle factors in contributing to poor health, and thus are stressing the need to maintain 
good health to reduce the health problems directly caused by lifestyle choices (Kricka & 
Price, 2009). Therefore, offering more choice to patients has been largely in part due to a 
shift in healthcare culture. The concept of patient autonomy7 in self-management 
continues to be an important healthcare debate. In healthcare decision-making, patient 
                                                 
7 Patient Autonomy: In biomedical ethics, autonomy is considered to be a principle of respect whereby 
patients are supported in making decisions about which healthcare interventions they will or will not 
receive (Entwistle, Carter, Cribb & McCaffery, 2010). 




autonomy suggests that self-diagnosis and ST are considered tools that aid individuals in 
taking a more active role in their own health (Grispen et al., 2010). It must be noted 
however, that despite good intentions, even the technological tools such as the POC tests 
now commercially available to patients, can potentially have adverse effects. Between 
1992-2009, the U.S. Food and Drug Administration reported one hundred fatalities due to 
inaccuracies with glucometers, and another 12 672 serious injuries8 were reported 
between 2004-2008 (Walsh, Roberts, Vigersky & Schwartz, 2012). Considering the rate 
of adverse events linked to inaccuracies with glucometer usage, it would not be incorrect 
to posit that adverse events occur with other POC tests as well, and must be more widely 
publicized. It is important to reflect on this data since ST is on the rise. Much of the 
existing research on POCT focuses on its usage within formal healthcare environments, 
as well as the convenience and satisfaction with POCT in home care environments. 
However, the literature does not address the full role of patient autonomy as a driving 
factor for ST, when considering the shift of routine laboratory tests into home care 
environments; therefore, this research presented a unique opportunity to examine the gap 
in the literature. This research study seeks to explore the value of patient autonomy in 
self-directed healthcare. In addition, the study examines the implications involved with 
ST and the production of lab test results that are used in clinical decision making and 
therapeutic health interventions, when testing occurs outside of regulated healthcare 
facilities. 
1.3.  Purpose of Study 
The purpose of this study is to understand the role of patient autonomy in ST and 
to examine the key decisions that influence patients to engage in ST. More specifically, 
the research examines patient autonomy from the perspective of patient participants who 
have diabetes. The study explores how patient autonomy, or the ability to self-monitor 
and self-manage a health condition, affects healthcare decision-making for both the 
patient and the healthcare provider. Finally, the research seeks to explore who is 
ultimately responsible for following up with the results of self-testing. In this qualitative 
                                                 
8 Serious injuries: includes, but is not limited to treatment with medication(s), hospitalization required, 
therapy/non-surgical treatment, hypoglycemia/hyperglycemia, loss of consciousness, shaking/tremors, 
dizziness (Harper, n.d.) 




research study, six patients and six primary care physicians participated in semi-
structured interviews to discuss their experiences with POCT, the resulting impact of ST 
to one’s health, and the impact of ST on the doctor-patient relationship dynamic.    
1.4. Research Objectives 
In order to explore the focus of the aforementioned research, the researcher 
created a specific set of research questions: 
1) What is the role of patient autonomy in healthcare? How does patient 
autonomy or ability to self-manage a health condition with a self-test affect 
healthcare decision-making for both the patient and healthcare provider? 
2) What influences patients to participate or not participate in self-testing? 
3) Who is responsible for following up with self-test results? 
To fulfill the purpose of this inquiry, the researcher developed a qualitative 
research study, that employed a set of semi-structured interview questions to engage the 
patient participants in discussions about elements of ST that impact their autonomy and 
healthcare. Data collection from physicians helped to produce a more comprehensive 
understanding of the impact of ST on patient care and to the broader healthcare system. 
In addition, the researcher collected brief demographic data from both patients and 
physicians through self-administered paper/electronic questionnaires, for additional data 
analysis. 
1.5. Overview of Research Study  
In summary, this chapter presents a brief background on the medical laboratory 
sector and the emergence of a new sub-sector known as point-of-care testing. The 
research questions are framed by providing an overview of existing accountability 
standards within the medical laboratory sector as well as highlighting how the shift in 
healthcare delivery has influenced patient autonomy in ST healthcare self-management. 
In Chapter 2, the researcher will discuss the literature review, and will focus on 
the gaps in the literature that make this research necessary. Chapter 3 will focus on the 
methodological approaches, including research design, participants and recruitment 
strategies, ethics review and data collection. Chapter 4 presents the results and data 
analysis of the study from patient and physician participants. Chapter 5 discusses the 




findings of the research study, presents study limitations and concludes with 
recommendations for policymakers and suggested areas for future research. 
  




Chapter 2 – Literature Review 
2.0.  Introduction 
This chapter will provide a brief overview of the literature search strategy, review 
the development of POCT and explore the elements of quality assurance in regulated 
healthcare settings that ensure POCT does not compromise patient care. In addition, the 
shift of POCT from healthcare settings to alternative environments and common themes 
that affect ST, will be examined. The focus of this chapter is to highlight the existing 
gaps in the literature that makes this research necessary. 
2.1  Literature Search Strategy 
To perform a search of relevant journals, several health science search databases 
were consulted. This included CINAHL, MEDLINE via. EBSCOhost, MEDLINE via. 
Ovid, Ovid SP, ProQuest Nursing and Allied Health Source and PubMed. These 
databases were mainly selected as they are considered to be the top databases to contain 
literature pertaining to health sciences. Keywords selected to perform the search were: 
point of care systems [MeSH Major Topic], attitudes or perceptions or experience. All 
searches needed to include point-of-care systems as the medical subject heading or major 
topic of the article, as the inquiry seeks mainly to gather evidence from this body of 
literature. Secondly, the researcher had selected ‘attitudes or perceptions or experience’ 
as the next important keyword in order to find relevant articles that would be capable of 
measuring or describing experience/attitudes/perceptions related to POCT. The search 
strategy also included a review of the reference lists contained within appropriate journal 
articles as a means to obtain other relevant literature. Inclusion and exclusion criteria are 
as described below: 
 Publication date from 2000/01/01 to 2015/12/31 - due to the change in technology 
in modern times, POC devices have become more advanced and more prevalent in 
healthcare. Therefore, the researcher chose to look at articles that were published 
after January 2000. 
 Humans – Article must only examine the use of POC devices on humans 
 English – Article must be in the English language 




Finally, articles were screened based on abstracts provided in the search database. 
Articles specifically excluded from the search strategy were those which discussed the 
use of POCT on specimens where capillary or venous blood was not the primary source 
of sample collected, as this research inquiry seeks to examine the experience of patients 
who use a POC device to manage their chronic illness using a capillary blood specimen. 
2.2. Self-Testing: Past, Present, Future  
Historically, urinalysis dipsticks and glucometers were among the very first tests 
available at the POC. Nowadays, some of the more commonly available POC tests 
include urine pregnancy tests, screening tests for the Human Immunodeficiency Virus 
(HIV), fecal occult blood testing, cardiac marker tests, and drugs of abuse testing 
(Lewandrowski, 2009). 
In the 21st century, marked innovations in technology have allowed the field of 
POC to grow and expand. Outside of traditional healthcare settings, POC tests have 
become commercialized for personal in home use, and have unique applications for use 
in transport vehicles9, prisons and military operations. Furthermore, they have proved to 
be especially useful in remote areas or in parts of the world where disaster and medical 
relief is required, or where the infrastructure may not be able to support a central 
laboratory (CAP, 2012). 
 The widespread availability of these tests has introduced the concept of ST to 
many individuals; instead of having to consult a physician to obtain a lab test result, 
many patients are now turning to ST, further engaging their role as autonomous patients.  
Free and Free (1984) describe ST to be an activity in which a lay person (one who lacks 
the resources of a laboratory, nor possesses the technical, medical or scientific training 
usually involved in the testing process) produces a clinical laboratory measurement. 
2.3. Point-of-Care in Healthcare Settings 
In a healthcare services setting, a POC test is often initiated by a physician’s 
order, a medical directive or a medical protocol, whereby the physician caring for the 
patient ultimately needs to take responsibility for the diagnostic value produced by the 
                                                 
9 Transport vehicles: ambulances, helicopters, airliners 




POC test. In the event that a questionable POC laboratory result is manifested when 
testing is conducted at the bedside, healthcare practitioners are able to verify the validity 
of questionable results by ordering a superior quality venous blood specimen for 
collection10, and referring the specimen directly to the laboratory for high quality testing, 
and ultimately, suitable clinical action if required. 
Of consideration is the abundant quantity of literature available that focuses on 
POCT and its use within well-established healthcare settings. Particularly of concern is 
the amount of research in this area which suggests that the decentralization of laboratory 
testing can have very serious consequences. Studies demonstrate that when non-lab 
personnel are involved in laboratory testing, patient care can be compromised, 
highlighting the necessity for quality testing at the POC (Plebani, 2009; Lippi, Guidi, 
Mattiuzzi, & Plebani, 2006). Poor operator training may compromise diagnostic values 
obtained from a POC test, if operators do not use the correct type/volume of sample, or if 
there is improper physical application of specimen to the testing surface/chamber of the 
device. The quality of specimen also can be affected by collection of insufficient sample, 
incorrect sample type or inability to detect interferences that may be present in the 
sample. Trained laboratory personnel would easily identify these sources of error in the 
pre-analytical phases of testing, and would act accordingly as it may affect the end result. 
Studies indicate that the lack of standardized protocols for procedures in specimen 
collection contributes to errors that occur in the pre-analytical phases11 of laboratory 
testing (Rana, 2012; Lippi et al., 2006). In addition, since most POCT does not occur 
under the direct supervision of laboratory personnel, there is great difficulty in 
monitoring all of the pre-analytical variables that could affect testing, hence the lack of 
process improvements in this particular area (Lippi et al., 2006). 
                                                 
10 High quality venipuncture samples are often collected by laboratory personnel, or other healthcare 
practitioners that are qualified to perform the procedure. 
11 The pre-analytical phase of laboratory testing begins at the moment when a laboratory test is ordered. It 
encompasses specimen collection from the right patient, at the right time, ensuring that an optimal 
specimen is collected, as well as following through with the correct steps for handling and processing 
specimen. 




2.4. Quality Assurance Programs 
Quality assurance programs enforced by laboratories in accredited healthcare 
facilities ensure POC regulation through mandatory quality assurance processes. This 
ensures that the laboratory values produced through POCT are validated by daily quality 
control assays, correct calibration of devices, correct lot number of in-use reagents and 
proper storage of reagents involved in the use of the clinical diagnostic tests. 
Additionally, quality standards within healthcare settings forces analytical methods to be 
evaluated by external quality assessments and proficiency testing. However, research 
continues to indicate that non-laboratory personnel do not have the same capability of 
performing and assessing the result of a diagnostic laboratory test, as they may not have 
the same level of understanding and appreciation of a quality management program 
within a diagnostic testing system (Ehrmeyer, 2011; Jones & Meier, 2005). There is 
currently no existing quality assurance framework in effect for POCT outside of 
regulated environments, and thus POCT conducted in personal homes are not subjected 
to the same level of scrutiny pertaining to the quality of test results obtained in a 
laboratory. This is a significant element pertaining to the safety of the testing process for 
patients. There are no external organizations monitoring personal POC devices or 
scrutinizing an individual’s testing technique/method to ensure that testing is being 
performed correctly. Furthermore, the International Organisation for Standardisation 
(ISO) and the Canadian Standards Association (CSA) detail specific standards for the 
safe and effective usage of POCT within healthcare environments; however, these 
standards specifically exclude ST that occurs in home or community settings (CADTH, 
2014; Appendix Q).  
Additionally, medical laboratory technologists, those who perform, analyze and 
report laboratory test results, represented <1% of the total labour workforce in Canada 
between 2011-2013 (Service Canada, 2015). This means that a significant portion of the 
general public may not fully appreciate the need for quality in POC as they may be 
incognizant in the area of POCT. Hence, the majority of end-users performing POCT in 
their own home may not be fully aware of the ramifications that may arise as a result of 
performing testing without a quality framework in place, which would essentially serve 
to promote their best interests. As POC is a fairly new area that continues to rapidly grow 




outside of clinical care settings, it is not surprising that standardization and regulation is 
still lacking. As a flaw-free system for POC in established healthcare settings has yet to 
be achieved, it is important to reflect on the likelihood that encountering challenges in 
alternative environments exist as well. 
2.5. Regulation and Accountability 
Systems of accountability for healthcare institutions and healthcare providers 
alike are well established within the province of Ontario. These mechanisms are in place 
in order to ensure that healthcare practitioners and healthcare institutions are accountable 
for their actions. On an individual level, many regulated healthcare practitioners are 
governed by, and answerable to, their respected regulatory colleges for all actions that 
may be related to patient care. On a much larger scale, in Ontario’s healthcare system, 
service accountability agreements are prescribed. These agreements contain a set of 
performance indicators to be met for those who plan, manage and deliver healthcare 
services in order to monitor financial and organizational health, as well as quality of care 
(OHQC, 2008). Finally, on an organizational level, quality assurance programs managed 
by laboratory services ensures that delivery of POCT is reliable. This includes but is not 
limited to ensuring that all non-laboratory personnel involved in POCT are trained to 
execute POC tests appropriately, ensuring there is satisfactory cross-correlation of POC 
tests with those offered at the central laboratory, and participating in external 
assessments12. The IQMH, AC and CMLTO further serve to promote accountability 
within Ontario laboratories. Laboratories work with these accreditation bodies to ensure 
that they are meeting benchmark standards and that reliable laboratory test results are 
being produced.  
The area of POCT continues to develop and expand outside of conventional 
healthcare settings. Decentralizing laboratory testing into such environments may have 
very serious consequences to patient care, considering the lack of standard operating 
procedures, regulation and accountability. Clearly, the implications of patient initiated ST 
need to be more closely examined. 
                                                 
12 Refer to Appendix Q and Appendix R which detail ISO standards as well as national and international 
requirements for quality management of POCT. 




2.6. The Shift in Healthcare Delivery 
There is a changing dynamic in the delivery of healthcare services – from 
inpatient to outpatient care settings, from provider-centered care to patient-centered care, 
and more recently in the delivery of home healthcare (Friedman & Mitchell, 1993; Park, 
2006). The shift in healthcare culture, notably in health promotion programs, emphasizes 
the concept of empowerment, particularly in relation to health and community 
participation (Robertson & Minkler, 1994). Generally, community empowerment is 
defined as the approach taken by individuals to involve themselves in a greater capacity 
in decisions that could affect their overall health and wellbeing (Laverack & Labonte, 
2000), and may sometimes be an explicit goal of health promotion programs. By focusing 
on increased control over health behaviour changes, or on the underlying health 
determinants13 that influence health and wellbeing, individuals become more actively 
involved in decision-making that ultimately affects their own health.   
‘Telehealth’ is one such model that facilitates home healthcare, which also can be 
considered an up and coming facilitator of POCT. The telehealth model utilizes a broad 
variety of methods and technologies to virtually deliver medical, health and education 
services (CCHP, 2010). Considering that POCT gives patients access to their own test 
results, the telehealth system could be of benefit if patients needed treatment decision 
support and assistance. In chronic disease management14, the telemedicine model has 
already proven to be quite beneficial when timely healthcare interventions are coupled 
with health promotion activities (Bashshur et al., 2014). Essentially, the telehealth model 
works to decrease the burden on the healthcare system by reducing hospital admissions 
and length of stay, patient visits to primary care physicians, walk-in clinics and 
emergency departments (CCHP, 2010; Bashshur et al., 2014).  
Considering the change in models of healthcare delivery, it is important to 
understand the current state of knowledge concerning patient and physician views of ST. 
Much of the existing literature on ST discusses the successes and pitfalls of ST within a 
                                                 
13 Health determinants: income, social status, environmental threats, housing, education, gender, 
employment (PHAC, 2008). 
14 The three chronic diseases included in the Bashshur et al., (2014) study include: congestive heart failure, 
stroke and chronic obstructive pulmonary disorder 




specific clinical context15. However, few studies have surveyed the attitudes of patients 
and physicians in a rigorous manner. In two separate studies conducted by Laurence et al. 
(2010) and Thompson, Ragucci, Fermo & Whitley (2009), patient levels of satisfaction 
between POCT and routine laboratory testing were examined. Research in these two 
studies indicated that patients felt more comfortable having a finger prick over a 
venipuncture to collect blood, that it was convenient to perform testing in the privacy of 
their own homes and that having immediate result feedback was important to their 
disease management, as well as strengthened their relationship with their primary care 
physician. On the other hand, laboratories were considered more hygienic and results 
were thought to be more reliable, although it was inconvenient and costly to go to a 
laboratory for the testing procedure. A systematic review of primary care clinicians’ 
attitudes of POCT primarily in European nations, conducted by Jones et al. (2013), 
identified the major barriers and facilitators to POCT.  Facilitators in primary care 
facilities included a cost/time savings, improved patient convenience, and increased 
satisfaction and health outcomes of patients. Barriers identified included the time 
required to use POC equipment, inaccurate results, inappropriate testing, and concerns 
over reliability of testing. A mixed methods study by Grispen et al. (2010) examined the 
role of autonomy in decisions to self-test. The study described the use of self-tests in 
patients who initiate ST by examining decisions to perform ST, as well as the conditions 
surrounding the execution, interpretation and follow-up behaviours associated with the 
self-test. However, the literature failed to contextualize patient autonomy in POCT in 
environments where there is currently no framework for regulation and accountability. 
Furthermore, each healthcare decision that a patient makes with the use of a self-
test has a considerable related ethical component when ST occurs in the privacy of one’s 
home. For example, Youngs and Hooper (2015) highlight the possible implications for 
good and harm, when using an at home HIV screening test. The authors indicate that ST 
can allow for an early diagnosis, thereby improving the patient’s prognosis and reducing 
chances for transmission of the virus. Conversely, false positives may cause undue 
emotional distress to patients, whilst false negatives may cause the ongoing spread of the 
                                                 
15 For example, consider studies examining the successes and barriers of self-monitoring blood glucose and 
anticoagulation status 




disease. Additionally, some patients may not even seek healthcare support in the event 
that they find out that they are positive for the disease, for fear of the stigma associated 
with HIV. Without clinical guidance from a qualified healthcare provider, patients may 
be at risk of incorrectly interpreting self-test results. Kearns, O’Mathúna and Scott (2010) 
argue that ST in the privacy of one’s home can negatively impact the individual if they do 
not have the proper support from a healthcare practitioner that can make sense of the ST 
results in a meaningful way.  
Many of the studies discussed above establish how ST can affect patients both 
positively and negatively. The research, however, fails to demonstrate why healthcare 
decision-making as it relates to ST and patient autonomy needs further attention. 
Evaluating the impact of ST initiated by the patient is still not completely understood, nor 
are the implications of participating in self-testing clear. Additionally, there is no clear 
chain of accountability for who is ultimately responsible for self-test results, when testing 
is initiated by patients. As the technology behind clinical laboratory sciences continues to 
grow, the need to capture patient and physician perspectives on ST further validates this 
research. 
2.7. Concluding Remarks 
The existing healthcare literature draws attention to the fact that no studies have 
been conducted to evaluate the utility and/or consequently the implications associated 
with ST in home-based settings, an environment lacking a formal regulatory process to 
ensure safety and quality testing at the POC. Conducting this research presented an 
opportunity for an original contribution to the field of POC, from an end-user’s 
perspective, with additional interviews with physicians who acted as key informants on 
the discussion of POCT within the community. This study allowed the opportunity to 
actively engage primary care physicians and patients in dialogue with the researcher, to 
provide rich descriptive qualitative data that will contribute immensely to the ongoing 
discussion about the impact of patient autonomy on personal health, with the context and 
impact of ST at the heart of the discussion.  
  




Chapter 3 – Research Methodology 
This chapter will discuss the research design and methodology, provide an 
overview of the data collection and data analysis methods, and will discuss ethical 
considerations pertaining to the study. A research timeline is included in Appendix M. 
3.0. Introduction 
Since POCT may fundamentally shift the accessibility of laboratory testing in the 
future, the scope of the research is to seek out an understanding of the implications of 
patients conducting self-testing in the community, how it affects patients and healthcare 
providers, and how it could affect the shape of healthcare in the future. In order to 
facilitate answering the goals of this qualitative research study, the research study sought 
out to examine the role of patient autonomy in POCT and chronic disease management, 
assess its impact to patient care, and to address the question of accountability in ST when 
ST is patient driven.  
The researcher’s role in this study included (a) establishing liaisons with primary 
care physicians and primary care facilities to aid in the process of recruitment for 
research participants; (b) completing formal research ethics application for review by the 
University of Ontario Institute of Technology (UOIT) Research Ethics Board to conduct 
research; (c) collecting data; (d) entering data; (e) analyzing data; (f) writing the thesis; 
(g) presenting and disseminating of findings. 
3.1. Research Design and Methodology 
This research study was qualitative in nature. Holloway (2005) indicates that 
qualitative research is important in healthcare to develop or modify existing health or 
education policies, and that exploring the need for change in health policies can only be 
effective if the underlying reason for health behaviours are understood. Wiersma & Jurs 
(2009) clarify that capturing the perceptions brought forth by participants in qualitative 
research exposes an accurate measure of reality from the participants’ perspectives. 
Therefore, “meaning is as perceived or experienced by those being studied; it is not 
imposed by the researcher” (Wiersma & Jurs, 2009, pp. 232-233). More importantly, 
qualitative health researchers provide a voice for individuals to share meaningful stories. 
In health care research, qualitative studies provide a means to convey how various forms 




of illness impact their relationships, work and leisure time, and provides insight into how 
these individuals choose to manage their future health related outcomes and how this 
relates to their eventual dying and death (Morse, 2012). Qualitative research can adopt a 
variety of methods and it involves an interpretive approach to understand the nature of 
the problem; this can be achieved by examining a range of empirical materials which 
describe “routine and problematic moments and meaning in individuals’ lives” (Denzin 
& Lincoln, 1994, p. 2). 
In order for the research to address the goals of this research study, the researcher 
used a case study informed methodology, adopting teachings from qualitative researcher, 
Robert Yin. This methodology is embedded within the interpretivist paradigm, one in 
which the researcher offers up a perspective that would help his or her readers to 
understand a particular phenomenon of interest (Willis, 2007). The interpretivist 
paradigm seeks to understand the lived experiences of individuals and the meanings that 
individuals attach to their experiences. Hennink, Hutter & Bailey (2011) explain that 
since each person’s perception of reality is subjective, numerous perspectives of the same 
reality may exist. This is just one of the many reasons why qualitative research can be 
useful to identify areas for improvement in healthcare.   
This research endeavour employed a case study informed approach to gain an 
understanding of a social sciences phenomenon in a comprehensive and detailed manner 
by extensively exploring a modern-day phenomenon within a ‘real-life’ context, 
especially when the boundaries between the phenomenon of interest and the contextual 
variables are somewhat blurred and not noticeably evident (Yin, 2009). This approach is 
best used in social sciences research that seeks to uncover the “how” and the “why” of a 
particular phenomenon. Case studies are also known for their strength in being a 
complementary method to other research methods (Yin, 2009). For example, research 
methods that involve the use of randomized trials16 may establish a “cause and effect” 
relationship, yet lack the ability to explain how/why a given intervention was successful. 
A case study method could successfully address this sort of a question. Finally, case 
studies are also considered to be the preferred method to examine present-day issues in a 
                                                 
16 Randomized trials look to prove causal relationships by observing a control group and manipulating a 
variable of interest in the other group (Sibbald & Roland, 1998). 




setting where the researcher has no influence over relevant behaviours. This involves 
interviews with research participants and the researcher’s direct observations of the 
events to be studied (Yin, 2009). In this particular research endeavour, a case study 
informed approach was used as a guide to help the researcher understand how ST is 
influenced by an autonomous patient decision-making process, from both the healthcare 
provider and patient’s perspective. 
3.2. Conceptual Framework 
The study design was guided by the use of a conceptual framework, in order to 
bring a greater focus to the concepts to be studied and the relationships that each has to 
the other (Maxwell, 2005). It was the researcher’s intention to use open-ended and 
loosely structured questions in an interview style, with probative questions as required, in 
order to engage in dialogue with the research participants. The researcher used a 
hierarchy of concepts (Appendix C) in order to organize the research and expose and 
highlight the links between the different levels of related concepts. Punch (2006) suggests 
that a hierarchy of concepts is governed by a process of logic whereby the relationships 
between the concepts are demonstrated by making general concepts more specific at each 
level of the hierarchy. Clearly indicating the different dimensions of related concepts 
involved at each level of hierarchy provides further internal consistency, coherence and 
validity to the research study (Punch, 2006). In addition, the conceptual framework 
served to direct questions that ultimately helped to address the role of autonomy in 
POCT, as well as touching on measures of accountability and regulation that should serve 
to promote the safety of patients conducting self-driven POC tests.  
To address the study’s research questions, the researcher designed a unique 
conceptual framework to guide this study. The conceptual framework used in this study 
merges the concepts from two key models: clinical governance and the health belief 
model (HBM).  
 The clinical governance framework is an invaluable tool in healthcare settings as 
it involves an established process by which patients and healthcare providers can work 
together to achieve quality at the POC. The framework itself serves to evaluate and 
explore the role of quality assurance, regulation and accountability in meeting the needs 
of POC users within the community. Pearson (2006) and Freedman (2002) describe 




clinical governance as a quality framework that encompasses risk management, clinical 
and cost-effectiveness as well as patient outcomes in the medical laboratory sector; it is 
essentially a systematic approach to quality assurance. Clinical risk management 
encompasses operator training, as well as education about the phases of laboratory 
testing, regular audits and competency checks (Pearson, 2006). In addition, management 
of clinical and cost-effectiveness is an important variable in the quality assurance 
framework as it is believed that POC tests enhance clinical care. This quality framework 
largely involves patients and healthcare providers, in the need to achieve quality at the 
POC. The quality framework is important in the field of POC because, in the long run, it 
largely affects so many aspects of the healthcare system (includes, but is not limited to 
cost, social determinants of health, health policy).  
The HBM is the second half of the conceptual framework. Patients managing 
chronic conditions are believed to be more compliant with treatment regimens when they 
take a more proactive approach to their own healthcare (Charuruks et al., 2006). The 
HBM plays a crucial role in healthcare autonomy and in guiding decisions to carry out 
POC tests (Appendix B). The HBM theory originally was developed in the 1950’s as a 
way to help understand how personal beliefs motivate individuals to engage in health 
promoting behaviours, including physician prescribed preventative actions and healthcare 
interventions (Graham & Pace, 2008). Hayden (2009) explains that the HBM functions to 
explain health behaviours independently or in combination, from four different angles. 
The first angle is perceived seriousness – the belief about the severity of a disease. The 
second angle is perceived susceptibility – the perception that prompts individuals to adopt 
healthier behaviours. The third angle is perceived benefits – the opinions on the value of 
adopting a behaviour that would reduce the risk of disease. The final angle is perceived 
barriers – the challenges that individuals may face in adopting new behaviours. More 
recently, the model has further developed to understand what prompts health behaviours 
(cues to action), how individuals face tasks and challenges (self-efficacy) and finally 
what factors motivate them to execute certain behaviours (Hayden, 2009). By examining 
what motivates individuals to engage in ST, how such behaviours come to exist, and what 
challenges may exist in ST, this model will help to create an understanding of why POCT 




may be considered of value in a world where autonomy in healthcare decision-making is 
considered to be of the utmost significance. 
No literature has been published which combines the HBM and clinical 
governance framework. Since the HBM and clinical governance models are 
interconnected, the conceptual framework was ideal in creating an understanding of the 
role of patient autonomy in POC, whilst identifying themes that pertain to elements of 
quality assurance, patient safety and a greater understanding of the physician’s role in 
POCT within the community. Fusing these two models created an opportunity for an 
overlapping and intersectional approach to examining the use of POC devices within the 
community, and in doing so, the quality of this research study was strengthened, as both 
models are relevant in complementary ways.  
3.3. Participants and Recruitment Strategy 
Since the research sought to gather the perspectives of both patients and 
physicians, two groups of participants were involved in this study. The researcher was 
able to form a liaison with a primary care physician in a medical clinic. With the help of 
this physician, the researcher was able to get permission to allow hanging a recruitment 
poster in two medical clinics (see Appendix D) to recruit patients for the study. In 
addition, with the help of the researcher’s medical liaison, the researcher identified 
primary care physicians who served as key informants in this research study. Once 
potential participants were identified, the researcher extended a formal letter of invitation 
to each participant, which included greater detail about the study. Finally, a signed letter 
of consent was collected from all participants prior to the initiation of data collection (see 
appendix G). 
3.3.1. Patient Inclusion and Exclusion Criteria. 
Patients were recruited at random from the medical clinics. Participants who saw 
the recruitment poster in the medical office voluntarily contacted the researcher, and the 
researcher provided additional details about the study. This strategy did not yield many 
participants, thus to increase patient participant recruitment, a change request was filed 
and approved by the UOIT Research Ethics Board (REB). The change request detailed 
the involvement of physicians at approved clinics, who would help to identify patients 




who would be eligible to participate in the study. As physician offices are often busy, two 
scenarios to recruit patient participants were possible. If there was time during the 
appointment, the physician would use the approved recruitment script to explain the 
research endeavour. If patients were interested in participating, they could take the 
recruitment script home with them, and contact the researcher to discuss further.  If there 
was no time during the appointment to use the recruitment script, the physician would 
notify the patient that the researcher is interested in talking to patients who would like to 
share their views of self-testing. The physician would ask consent to share the patient's 
contact information, or alternatively, the patient could leave their contact info at a sign up 
sheet with the reception desk, which the researcher would later collect. The researcher 
could then contact these patients, and use the approved recruitment script to further 
explain the details of the study. In both scenarios, the physician and/or the researcher 
would make it clear to the patient, that if the patient chooses to participate, or not 
participate, that it would not affect the patient's healthcare services, nor would it affect 
the physician-patient relationship, and it would not impact their level of care in any way. 
All patient participation remained completely voluntary. 
Participants who met the inclusion criteria were enrolled in the study. Inclusion 
criteria for the patient pool included recruitment of participants who were 18 years of age 
and older, of any gender. In order to participate in the study, it was also required that 
participants be using a glucometer for a minimum of at least three months as part of their 
diabetes illness monitoring and treatment regime. These criteria were listed as inclusion 
criteria in order to homogenize (as best possible) the population of patient participants. In 
this manner, patients who were interviewed shared common experiences of self-testing. 
Patient participants who acknowledged that they had a background in clinical sciences 
were excluded from the study, as their knowledge of POC services may have produced 
indistinct/dichotomous themes (when compared to/against participants with no clinical 
sciences background) after the analysis stage of research was completed. Additional 
exclusion criteria included participants who were under the age of 18, participants who 
did not have diabetes, participants who did not participate in self-testing with a 
glucometer, participants who did not regularly seek healthcare from a physician, and 
participants who did not seek care from a physician at the medical clinics. 




3.3.2. Physician Inclusion and Exclusion Criteria 
Physicians as key informants, were recruited using convenience sampling, a 
purposeful sampling strategy in which participants are recruited because they may be 
convenient to study; this technique is also thought to save time, money and effort 
(Creswell, 2013). 
The physician inclusion and exclusion criteria were quite simple. Licensed 
primary care physicians who were currently practicing were eligible to participate in the 
study, as they often treat patients with diabetes who self-monitor blood glucose. 
Physicians who were not licensed or practicing in an area of primary care were excluded 
from the study. It was essential to get the views of only practicing physicians, as they are 
actively engaged in patient care, as it pertains to their profession. 
3.4. Sampling 
A total of six patient participants and six physician participants volunteered their 
time to share their views and perspectives of ST with the researcher. All twelve of these 
participants met the inclusion and exclusion criteria to participate in the research.   
An additional four patients were invited to participate; however, they did not 
partake in the research study. Two of these potential participants cited ‘unavailability of 
time’ to participate in the research study. The other two potential participants did not 
respond to researcher enquiries about scheduling interview dates, despite multiple efforts 
to contact the patients.  
An additional 15 physicians were invited to participate in the study; two 
physicians declined to participate, citing ‘lack of time’ as the reason for their 
unavailability. Despite multiple efforts by the researcher to contact the other 13 
physicians, no responses were received.  
To ensure confidentiality of participants, each patient and physician was assigned 
a generic code. Patients were coded as “PT1, PT2, PT3, etc.”, and physicians were coded 
as “PY1, PY2, PY3, etc.”. 
3.5. Ethics Approval 
Prior to conducting the research protocol, ethics approval was sought from the 
UOIT REB. The application was submitted to the REB on Sept 15, 2016 and approval 




was granted December 19, 2016.  Recruitment of patients and physicians officially began 
February 03, 2017. Participant data collection spanned a period of two months from 
March 08, 2017 to May 19, 2017.   
All participants were given the opportunity to read the consent form and were 
given the opportunity to ask questions about the research prior to the commencement of 
the semi-structured interviews. Participants were also notified of their right to pause or 
end the interview, if they felt it was too difficult to speak about their experiences, and 
were notified of their right to voluntarily withdraw from the study at any time, with no 
consequences. 
3.6. Data Collection 
The primary method of data collection was semi-structured interviews. In 
addition, the researcher also collected demographic information from the participants 
through a self-administered paper/electronic questionnaire. The section below describes 
the details of the data collection process.  
The research sought to obtain these experiences from a homogenous population of 
end-users (i.e.: glucometer users), in order to identify common themes that influence ST 
among patients. Additionally, physicians acted as key informers, sharing their views 
about the effect of ST on patient care.  
The use of semi-structured and general open-ended questions were instrumental in 
creating dialogue to uncover and reconstruct various aspects of the lived experiences of 
the diabetic patients using glucometers to manage their disease. Individuals suffering 
from a chronic disease are often subject to other comorbid conditions that can alter their 
health negatively (CDC, 2016). This represents a vulnerable population of individuals 
who may seek comfort in knowing that they can rely on a clinical test to obtain results 
reasonably quickly and monitor their disease state themselves. Conversely, it may 
provoke greater fear in that patients may perceive testing to be lacking in accuracy and 
precision, therefore making disease treatment in their home somewhat unreliable.  
As the study was designed to collect data from two groups of participants 
(patients and physicians), a separate interview guide for both groups was generated and 
structured such that the pool of questions for both physicians and patients were as similar 
to each other as possible, in order to answer the research questions. By mirroring these 




questions, the intention was to capture key perspectives from both groups and understand 
how ST impacts both the patient and the physician, and furthermore understand the role 
of autonomy in ST. Additionally, this allowed the researcher to look for similarities and 
themes in responses between the two groups of participants during the data analysis 
phase.   
3.6.1. Semi-Structured Interviews 
In the research process, interviews are considered to be a practical and effective 
method to collect data as they can provide valuable insight into a given topic from the 
participants’ perspectives. In particular, the interviews can be focused directly on the 
phenomenon of interest, and may lead the researcher to explore other sources of evidence 
(Yin, 2009).  However, there are also some disadvantages associated with conducting 
interviews. Yin (2009) suggests that reflexivity may be inherent in interviews, as the 
research participant may only be giving the researcher what it is they think the researcher 
wants to hear. Furthermore, if the participant misunderstands the questions, the 
participant may not be able to clearly describe experiences. In order to address potential 
shortcomings of the interview questions, the researcher included probing questions in the 
interview guide in order to encourage participants to further elaborate on the interview 
questions.   
Prior to interviewing the participants, the researcher collected the signed informed 
consent forms, ensured that any questions they had about the study were answered, and 
also that participants were aware of their right to withdraw from the study. Participants 
were given the option to conduct a telephone/skype/face-to-face interview at a date/time 
most suitable to both the researcher and the participant.   
Two face-to-face interviews with patient participants were conducted at a local 
library in a private meeting room. The other four patient participants preferred to engage 
in telephone interviews. Patient interviews lasted on average 26 minutes in length; the 
longest interview was 40 minutes in length and the shortest interview was 15 minutes in 
length.   
Three face-to-face interviews with physicians were conducted at the physician’s 
medical clinic in a private meeting room. One physician chose to participate in a Skype 
interview, and another two physicians participated in telephone interviews.  Physician 




interviews lasted on average 30 minutes in length; the longest interview was 43 minutes 
in length and the shortest interview was 24 minutes in length.  
The interviews were conducted using an interview guide developed by the 
researcher, in order to facilitate answering the primary research questions. Please refer to 
Appendix L for a copy of the patient interview guide, and Appendix J for a copy of the 
physician interview guide. 
All transcription of the recorded interviews was completed by the researcher, and 
is further described in section 3.8.1.1.  
3.6.1.1 Advantages and Disadvantages of Face-to-Face, Telephone and 
Skype Interviews 
Face-to-face discussions are considered to be the gold standard in qualitative 
research interviews (Novick, 2008).  To begin, there are no literacy conditions required of 
research participants and it is thought that participants may feel a greater sense of 
openness during the interview process and that a face-to-face interview increases the 
ability to collect contextual data (Bowling, 2014; Novick, 2008). Face-to-face interviews 
allows the researcher the opportunity to ask detailed questions and probe for more 
information when required, however, it also enables researchers to display visual and 
feedback cues, which may affect data collection (Novick, 2008). Additionally, face-to-
face interviews can be both costly and time consuming (Novick 2008).  
The use of telephone interviews in quantitative research methods has been widely 
studied, is generally well accepted, and is noted to be the most commonly used method of 
survey data collection within industrialized nations; they produce high quality data that is 
rich, descriptive and detailed (Novick, 2008). Telephone interviews are thought to save 
the researcher time and costs associated with travel, while simultaneously allowing them 
to reach a more geographically extensive pool of research participants, and are 
proclaimed to ameliorate the safety of the interviewer (Novick, 2008). Within the 
qualitative realm, the aforementioned advantages apply, as well as allowing research 
participants the opportunity to remain within a comfortable environment of their own, 
providing them the opportunity to speak more freely, increasing the perceptions of 
anonymity, and allowing participants to share sensitive information which they may not 




have felt comfortable sharing in person (Sturges & Hanrahan, 2004). Furthermore, they 
are thought to reduce face-to-face feedback cues (Novick, 2008). Although not 
encountered in this particular research study, the lack of telephone coverage availability 
for some research participants is thought to be a disadvantage (Novick, 2008). Novick 
(2008) also reports that multiple qualitative researchers suggest that telephone interviews 
need to be brief, reducing the depth and richness of the interview, and that the absence of 
visual cues in telephone interviews can impair the quality of the data produced, however, 
there is little evidence to support these claims in qualitative research.  
Skype is a telecommunications computer software, designed to allow end-users to 
participate in video or voice calls for free (Skype, 2017). The use of Skype in qualitative 
research interviews combines the advantages and disadvantages of both face-to-face 
interviews and telephone interviews.  
As suggested by Burke and Miller (2001), researchers are encouraged to establish 
a rapport with research participants prior to engaging research participants in discussion 
about the phenomenon of interest. This act was facilitated by extending a formal letter of 
invitation to all research participants, which included details about the purpose of the 
study (see Appendix E and Appendix F). In addition, the interview guide was 
communicated ahead of time so that all participants had a chance to further reflect on 
their responses prior to the interview; it is thought that this enhances the quality of the 
data shared by the participants (Burke & Miller, 2001). Furthermore, research 
participants in this study were not forced to complete the interview protocol within a pre-
defined time limit, regardless of interview modality. All data produced from the study 
provided generous rich, thick descriptions which contributed to theme generation. 
3.6.2. Self-Administered Questionnaire 
In order to gather demographic data about the research participants, a self-
administered questionnaire was provided (see Appendix I and Appendix K). Research 
participants were given a choice to answer the questionnaire either electronically or on a 
hard copy, depending on their preference.  
Patients were asked to specify an age range, gender, a range for the number of 
years performing self-testing, a range for their total income level for the previous year, 
their highest education level, their current employment status and finally the employment 




industry that best fit their current employment status. Physicians were asked to specify an 
age range, gender and the number of years worked as a practicing physician. These 
questions were designed to allow for a better understanding of the population involved in 
self-testing, as well as understanding the views of the individuals who provide medical 
care to patients.   
3.7. Data Saturation 
The data collection phase concluded when data saturation was reached. The 
number of participants required to reach data saturation is influenced by a number of 
factors, discussed by Morse (2000). First and foremost, by focusing the scope of the 
study and creating a clear and concise topic to be studied, participants are able to provide 
in-depth rich, qualitative descriptions of their experiences. This narrows the focus of the 
experiences shared by participants and helps to create unified themes. Next, the 
researcher must consider the quality of the data produced in an interview, as some 
research participants lack focus and may not communicate their experiences well; on the 
other hand, some research participants may be quite articulate and expressive about the 
topic being studied (Morse, 2000). Furthermore, Morse (2000) indicates that the 
researcher may be able to reach data saturation by also considering the study’s design and 
the quality of the data produced. Guest, Bunce, & Johnson (2006) argue that interview 
structure, content and participant homogeneity are essential in reaching data saturation. 
Therefore, when participants share similarities in experiences with respect to the 
phenomena being studied, data saturation can be achieved sooner rather than later. In the 
analysis phase of the research study, the goal was to look for high-level, dominant and 
overlapping themes; once these dominant and overlapping themes became recurrent, data 
saturation was reached. Guest et al. (2006) explain that basic elements for metathemes 
may be present as early as one to six interviews. 
3.8. Data Analysis  
3.8.1. Data analysis of semi-structured interviews 
Analyzing the data produced from the semi-structured interviews occurred in two 
steps. The first step involved transcription of the interview data. The second step 
involved thematic analysis of the data. 




3.8.1.1. Transcription of Semi-Structured Interview Data 
The researcher transcribed all of the recorded interviews. If any identifying 
information was released during the interview process, it was removed from the 
transcribed report. In order to ensure the accuracy of the transcribed interviews, the 
researcher listened to the audio tapings a second time alongside the transcribed report, 
and also attempted to have all transcriptions completed within a period of 48 hours. The 
transcribed data was made available to the research participants in order to reaffirm their 
statements; this is referred to as member checking. All research participants were given 
the opportunity to review their interview transcripts in order to confirm that an accurate 
interpretation of the interview data was made. Participants were given seven days to 
review the transcribed interviews. No research participants indicated that they would like 
to modify their transcripts. Once the seven-day period was up, all audio recordings were 
deleted and transcripts were finalized. 
Once all of the interview data had been transcribed, the researcher organized the 
responses by interview questions to simplify the data analysis process. The researcher 
began the data analysis phase by reading and re-reading interview transcripts multiple 
times, while making memos as the transcripts were read. These memos helped to capture 
ideas, short phrases or key concepts (Creswell, 2010) that appeared during this process. 
Creswell (2010) suggests that this process allows the researcher to be well immersed into 
the details of the data and to get a strong grasp of the overall sense of the interview, 
before the researcher breaks it down into categories or parts.  
Analyzing the data produced by a case study informed approach can utilize a 
variety of techniques. The technique chosen to analyze the data depends on the type of 
case study; techniques can include pattern matching, explanation building, time series 
analysis, logic models and cross case synthesis (Yin, 2009). In this explanatory case 
study research, explanation building was the technique used to analyze the data. Research 
questions are posed to help understand events that occur, but are not understood. 
Explanations presented in case study research provide answers to specific research 
questions. Explanation building is a suitable technique for this research study as this 
technique is designed to find a compelling explanation as to why a particular 
phenomenon exists as it does. As a result, an inductive and inferential mode of reasoning, 




as opposed to deductive reasoning, is used in explanatory case study research (Belk, 
2010). 
3.8.1.2. Coding and Thematic Analysis with NVivo 11™  
Successful data analysis is influenced by the researcher’s familiarity with the 
tools available at their disposal to process and interpret research data. Lee & Fielding 
(2004) discuss a battery of tools that may be available - they include literal tools 
(physically concrete tools), conceptual tools (theoretical or methodological approaches) 
or operative tools (specific procedures such as segmenting, coding, abstracting, etc.).  
Over the past decade, one of the tools that has emerged are computer software 
packages; they have been created to aid in helping the researcher to decipher, code and 
categorize large amounts of qualitative data that may be the result of interviews, narrative 
texts or written materials. Prior to the analysis process, the researcher needs to define an 
initial set of codes and connect them to the research design. It is suggested that the 
researcher build codes to help in the data interpretation phase, as well as examine the data 
for emerging themes. Creswell (2010) explains that themes are considered to be ‘broad 
units’ of information that consist of multiple codes which are grouped together to form a 
single idea. The software packages then aid the researcher to identify codes/outputs to see 
if any patterns emerge (Yin, 2009).  
In this qualitative research study, the computer software package, NVivo 11™ 
was selected to complete the data analysis and interpretation process. NVivo is designed 
to provide a powerful analysis of textual data by organizing, analyzing, and finding 
connections in unstructured qualitative data such as interviews (QSR International, 2000). 
The first step in the data analysis procedure was to upload the semi-structured interviews 
into the NVivo software. Next, data analysis was guided by the conceptual framework 
devised for the study by the researcher. The researcher built an initial set of codes to look 
for emerging themes. The data was further subjected to several levels of coding using the 
NVivo software program to categorize similar characteristics and identify groups and 
subgroups of themes. 




3.9. Storage and Retention of Research Data 
Confidentiality of data was ensured through the use of Google Docs via Google 
Apps for Education (UOITnet server). All of the data collected was transcribed and 
stored on the UOITnet server, and was only accessible by the researcher. An interview 
transcript was provided to each participant in an electronic or hardcopy format. Member 
checking thus also served to further reaffirm the statements made by the participants, in 
order to increase the validity of their statements. All audio recordings were deleted once 
they were transcribed by the researcher. All data was anonymized to remove the risk of 
future re-identification of participants. All data produced from the study was destroyed 
upon the study's completion. All data housed on the UOITnet server was deleted and no 
electronic or hard copies of the data were kept. These steps ensured confidentiality 
throughout the research study process. 
3.10  Ensuring Trustworthiness in Qualitative Research Methods 
 
A number of frameworks exist which help to assess the rigour and trustworthiness 
of qualitative research findings (Baxter & Jack, 2008). The basic foundation for a well-
written research study is guided by a well articulated case study research question, and 
evidence which supports the need to perform the research (Baxter & Jack, 2008). The 
researcher in this study executed a thorough literature review, highlighting the gaps in the 
literature which further demonstrate the need to conduct this study. Baxter & Jack (2008) 
further stipulate that an appropriate research design and sampling strategies are 
necessary, and that the data are collected and analyzed in a systematic way. In this 
research study, the researcher provides thorough detail (in the above sections of chapter 
3) regarding the elements pertaining to research design, methodology, conceptual 
framework, participant recruitment strategy and data analysis, which demonstrate high 
levels of organization within the study.  
Yin (2009) also proposed four criteria to be used in case study research to ensure 
the validity of the research and findings: internal and external validity, construct validity 
and reliability. In the following paragraphs, the researcher establishes how validity was 
demonstrated.  




Internal validity refers to the establishment of a causal relationship between 
variables of interest (Yin, 2009). In this qualitative study, the researcher achieved internal 
validity using explanation building as a technique (as described in section 3.8.1.1.) to 
construct meaning and explain why the phenomenon exists as it does. 
The concept of analytic generalizations is used to generalize research findings to a 
broader theory, and the research design phase is considered to be a key component of 
ensuring external validity (Yin, 2009). Using analytic generalizations, the researcher was 
able to link the research findings to broader theories described in the conceptual 
framework, such as the HBM and clinical governance framework. Furthermore, the 
discussion portion of the research paper illuminates additional theories, which further 
connects patient autonomy and self management, especially in the context of chronic 
diseases. 
Yin (2009) explains that the purpose of construct validity is to identify whether 
the correct operational measures were selected for the concepts to be studied. This was 
accomplished using converging lines of inquiry in a connecting manor to further establish 
a chain of evidence. The triangulation of both patient and physician perspectives on the 
same phenomenon of interest helped to achieve construct validity. Additionally, 
experienced researchers were enlisted to challenge drafts of the completed thesis for a 
peer review, to help identify gaps or where additional clarification was necessary.    
Finally, reliability is considered to be a dimension of trustworthiness, which 
serves to reduce errors and biases which may be present in a research study by 
developing a case study protocol and database as if each stage in the protocol was being 
audited (Yin, 2009). In order to ensure reliability, the researcher systematically 
documented each and every research step taken. Dependability of the research findings 
was enhanced using a code-recode procedure (Krefting, 1991). In this tactic, the 
researcher coded all of the data, and later returned to recode the same data after a number 
of weeks to ensure that the same findings were generated. 
 




Chapter 4 – Results 
4.0. Introduction 
This chapter presents a description of the participants obtained by demographic 
questionnaires for patient and physician participants. Also presented in this chapter are 
the results of the data analysis from the open-ended semi-structured interviews with 
patient and physician participants. Results from both the contextual and conceptual 
phases of the research are presented and major themes are identified. Minor edits to 
participant quotes have been made in order to omit unnecessary repetitions and to 
increase readability of direct quotes, whilst maintaining the integrity of the data. 
4.1. Description of Patient Participants 
A total of six patients participated in this qualitative inquiry. A table summarizing 
the patient demographics is found in Appendix S.  
Sixty-seven percent (4) of the patient participants were male and thirty-three 
percent (2) of the patient participants were female. The patient participants varied in age 
from 56 to 90 years old and patients indicated that they had been self-testing (not limited 
to glucometer usage) from a range of 0 to 25 years. All patient participants indicated that 
they are retired from the workforce.  
Only five of the six patient participants specified their highest level of education 
completed. Two patients indicated that they did not obtain a certificate, diploma or 
degree; one participant indicated that they had completed a high school diploma or 
equivalent; the final two participants indicated that they completed a college diploma.     
Three patient participants indicated that their total income level for the year 2016 
was greater than $35K and all three of these participants identified ‘manufacturing’ as 
their employment industry.  The other three participants declined to specify their total 
income level for the year 2016; however, they described ‘business, building and other 
support services’, ‘information, culture and recreation’ and ‘educational services’ as 
those that best matched their employment industries. 
4.2. Description of Physician Participants 
There were also six physician participants in this qualitative inquiry. A table 
summarizing the physician demographics appears in Appendix T.  




Physicians varied in age from 26 to 55 years of age. Half of the physician 
participants were male and the other half of the physician participants were female. Two 
physicians indicated that they had only been practicing medicine for 0 to 5 years; another 
two indicated that they had been practicing for 16 to 20 years. The other two physician 
participants specified that they had been practicing medicine for 26 to 30 years.  
4.3. Data Analysis – Contextual Phase 
The contextual phase of the data collection was an important aspect of the 
research, as it helped to build a greater understanding of the stories and perspectives 
brought forth by both patient and physician participants. The data collection questions 
helped to provide some background on the research participants, and in this manner, the 
researcher was able to contextualize the responses received from the research 
participants. 
4.3.1 Data Analysis - Contextual Phase for Patient Participants 
The contextual phase of the data collection for patient participants was created to 
gain an understanding of the participants’ awareness of their illness and how it affects 
their everyday lives. This background information provides a brief contextual 
understanding of how the participants viewed their world. 
All patients who had participated in the research endeavour had been diagnosed 
with ‘diabetes’ for a minimum of five years. Patient participants generally had a varying 
range of knowledge of diabetes. PT3 indicated that she was aware that the diabetes 
diagnosis would become imminent, as she was first classed as pre-diabetic for a number 
of years. PT1 who had been diagnosed for over 25 years, shared a multitude of emotions 
that he had faced over the years with a diagnosis of diabetes, the struggles faced with the 
illness, as well as how living through the diagnosis had challenged and changed his life 
for the better. His experience with the illness has led him to become a peer-educator 
within the community for other patients diagnosed with diabetes. He describes his 
experience of living with diabetes:  
“Other people; getting them to understand what you are going through. What you 
are dealing with - because diabetes is not visible. It's an invisible disease that 
attacks from within. And that's the scary part, cause whether you have low sugars 
or high sugars, both ways are gonna get you. And you have to stay in the middle. 




And that's the main thing which I'm bad at – it’s so hard. Because I always say 
too, every diabetic cheats.  Doesn't matter who it is; what you're doing. It's just a 
statement that I use. You could go out for supper and not even realize - your 
starch, there's sugar in there, which becomes sugar. And your sugar goes up. So, 
I've learned that, yeah, certain things like Chinese food, I can no longer have. You 
know like those things. My son comes over, and him and his wife they go and get 
Chinese food [patient quotes:] “Well, I'm sorry I have to make my own…” 
Otherwise my sugar, it’ll go through the roof. And those are just little things that 
you learn as you go along…It seems like everybody’s against you, but they're not, 
they just don't know what's going on. I wish more people, the classes that I teach, 
that more people who don't have diabetes would come, because you can learn a 
whole lot there... on what your partner, or your mother or father is dealing with 
when they have diabetes. And that's the biggest thing, how to cope with them.”  
While PT1 described his experience of living with diabetes on a more personal 
level, PT3, shed light on the prevalence of diabetes within our society and made reference 
to the immense cost that diabetes has on our healthcare system, and the impact it has on 
her family as well. 
“Well I know it's very prevalent in our society. I know that it leads to many health 
problems. I mean I can list the health problems, but you are probably aware of 
those too. It seems to be more and more people developing it. And people develop 
it; young children develop it now, more. And then, it seems to be the age. Cause 
I'm 74. There seems to be – like my brother had it and he had it when he was 
about 70. And it seems to go and families. My brother-in-law, he had it. And my 
husband’s uncle had passed away with it way back years and years ago, before 
there was anything like insulin. So I think it's very much family. I'm sure it 
costing the healthcare system mega bucks too.” 
PT4, PT5, PT6 and PT8 spoke of their knowledge of diabetes on a broader scale, 
and shared what they knew about the disease itself.  
“I know that your pancreas doesn’t produce the insulin.” – PT4 
PT5 recognized the importance of making healthy food choices, a sentiment 
which was shared by all of the participants:  
“I know you have to stay away from the sweet stuff. You have to eat right. Like 
when we went to… [the dietitian], they told us all, and we stuck to it. My wife got 
so that she cooked right. You know. And I know diabetes isn’t too good if you get 
it.” 
Furthermore, patients reported that the monitoring of their diabetes with routine 
bloodwork drawn at their local laboratories, sometimes created feelings of anxiety and 




unease. Patients explained that phlebotomists who have drawn their blood with poor 
technique oftentimes leave them with a hematoma17  or create pain and soreness at the 
site of the venipuncture18 . They share their experiences of poor blood draws below: 
“If somebody is poking at you, and they leave you like black and blue... I know 
this one girl, I refuse to let her, cause she goes in and then she goes like this 
[motions to phlebotomist moving needle around in arm]. No thank you. I come 
out, and I can't use my arm for the rest of the day.” – PT1 
 
“I go up there to this place where they take your blood, and there's women in 
there that I don't think they should be taking your blood test. They put [the 
needle] in, and put it in about that far [shows approximately 3 cm of distance into 
vein]. And the other thing is, they put a bunch of alcohol on it, and don't wipe it 
off, and that stings. It hurts. One day, I said ‘ouch that hurts’. She says ‘do you 
want me to take it out?’ I said ‘well you got to do it - so finish it.’ It didn't hurt that 
bad, but it stung. There's some women, you don't even know they put the needle 
in!  See this here [shows site of blood draw]. That's the size of a quarter and 
there's a bump... I don't like to complain, but, I know there's two women over 
there, [and] I’m gonna say ‘can you get me anyone else?’ Cause it hurts. And it 
causes that kind of stuff [points to hematoma].” – PT5 
 
This routine procedure was portrayed to be a negative experience by the patient 
participants. 
4.3.2. Data Analysis – Contextual Phase for Physician Participants 
Data collection for physician participants in the contextual phase was designed to 
gain an understanding of the physicians’ awareness on the usefulness and availability of 
POCT within the community. Physicians spoke of overall awareness of self-tests that are 
used in monitoring chronic conditions, as well as various screening tests. Physician 
participants were generally well aware of the availability of self-testing on the market and 
widely viewed these tests in a favourable manner. They describe their experiences below: 
“There are a lot of different tests available that are used and can be helpful. 
Pregnancy tests. Fertility tests. Glucose testing. I’m sure there’s more.” – PY2  
 
“I agree that self-testing is definitely more widely available to patients now, and I 
think that's a good thing” – PY6 
                                                 
17 Hematoma: “A circumscribed collection of blood, usually clotted, in a tissue or organ, caused by a break 
in a blood vessel” (Dictionary.com, 2017). 
18 Venipuncture: “The puncture of a vein for surgical or therapeutic purposes or for collecting blood 
specimens for analysis” (Dictionary.com, 2017). 





“I guess in my opinion, it [POCT] kind of depends on what it's used for, and who 
it's used by. I think self-testing and point-of-care testing, I think that its great that 
that’s available because it just kind of removes some of the obstacles to patients 
accessing their own health information, and also gives them some agency in 
managing their own health conditions. So I think that’s a big benefit. It also 
allows in chronic conditions that require frequent monitoring, it just allows you to 
get more data points, much more easily versus if they have to travel to the clinic, 
or of they have to wait and see their health care provider until they get their 
feedback. It just lets things be a bit more immediate to them. So, I think it's very 
valuable and I’m sure it’s something we will use more and more.” – PY3  
Additionally, PY4 and PY1 remarked that the availability of ST for diabetic 
patients checking their blood glucose at home has been supported by the removal of 
obstacles associated with this form of ST, as well as various interdisciplinary teams 
working together to help promote the utility of self-monitoring in the diabetic population. 
They share their experiences below: 
“[Testing] has become more available.  Part of it is the interdisciplinary teams. 
So, physicians are giving the same message as pharmacists, as the diabetic clinics, 
and I feel everyone is working together to help support the availability. One thing 
that’s very helpful is that the glucometers are generally provided free of charge to 
the patient.  So that gets rid of a lot of barriers. And as long as the test strips are 
covered by a private insurance plan or the Ontario Drug Benefit Plan, then that 
also removes a barrier to testing.” – PY4  
 
“Glucose monitors, by and large, have been made free to patients, through 
different pharma companies, facilitated by diabetes education centers and by local 
pharmacists, which has been a big plus.” – PY1 
4.4. Data Analysis – Conceptual Framework Phase 
In order to identify important themes presented in the data, the researcher returned 
to the conceptual framework to guide the data analysis process. In keeping with the goals 
of the research objectives, the data collection questions were designed to answer the 
following questions: 
1) What is the role of patient autonomy in healthcare? How does patient 
autonomy or ability to self-manage a health condition with a self-test affect 
healthcare decision-making for both the patient and healthcare provider? 
2) What influences patients to participate or not participate in self-testing? 
3) Who is responsible for following up with self-test results? 




For patient and physician participants, the conceptual framework phase was 
devised to seek an understanding of each participant’s views of the value of self-testing, 
the role of autonomy in healthcare decision-making, various aspects of safety related to 
ST, and finally how ST would or could change the patient/physician dynamic, both short-
term and in the long-term. 
All data that is presented was further triangulated by comparing themes that 
emerged from both the patient and participant groups. During the data analysis process, 
numerous themes common to both patient and physicians were identified and are listed 
below. 
4.4.1. Impact of Self-Testing to Chronic Disease Management  
ST has proven to be a useful tool in chronic disease management, as is described 
by both patient and physician participants.  In this section, the researcher presents the 
data as two sub-themes of the impact of ST to chronic disease management: increased 
self-satisfaction and lifestyle adjustments. The data collected suggests that overall, the act 
of ST creates positive, happier and healthier outcomes for patients in the long run. 
4.4.1.1. Increased Self-Satisfaction 
In the setting of a diabetes diagnosis, patients explained that monitoring their 
blood glucose at home was an important aspect of decision making related to their 
healthcare. In the section below, they explain that the immediate feedback of a blood 
glucose value led to greater self-satisfaction of their current health status, allowed 
patients to consider making changes to their diet, exercise plan and lifestyle, as well as 
being able to confirm or re-affirm their clinical status when they were feeling 
symptomatic of the disease. 
“If I’ve overindulged in something, then I can then I can check right away, and 
then I know that I better watch it the rest of the day too. So, I think it's great. I 
think it's the way to keep a tab on your food intake.” – PT3 
“If my self-testing is normal, I feel good about it. If it’s high, I want to know why 
it was so high; or if I know the reason why it’s so high, I cut it out.” – PT4 
“When I take my NovoRapid, I test before and then two hours after. So there's six 
times right there. Before each meal, and after each meal. And then you have 
morning and night. So it adds up. And when you see the overall picture…when I 




do it in the morning - if it's between 6 and 8, or 4 and 8 - it's perfect. If it's over, 
then I think ‘what did I do wrong?’ It gives you a good idea, ‘Okay, I had too 
much cheese or too many crackers, or my snack with my insulin was too much’. 
So then you have to reduce it. It does help you.  And then when you get up the 
next morning you see your sugar is between 4 and 8… ‘Okay I did something 
right’. Then that way, it does show you.” – PT1 
“Well I think it [self-testing] can confirm, at times, why you are feeling like 
you're feeling. You know, I think ‘oh I have a feeling my sugars are low’ and you 
can act on that if in fact you actually do get a low reading.”  – PT6 
“You know, it's a freedom thing. Like every time you do that, it frees you. And if 
I don't do it for three or four days, and I do it, and it’s still good, I’m still free.” – 
PT5 
4.4.1.2. Lifestyle Adjustments 
Lifestyle choices are an important element of disease management in diabetes. 
Patients shared that a diagnosis of diabetes meant challenging the way one thinks and 
behaves, as well as adjusting their daily routines in order to improve their own outcomes. 
PT1 explains: “If you want to be around, you better [take charge]! That's the main thing. 
I’m not perfect. I still have high sugars. But you try to watch it; you try to keep an eye; 
you try to do your best.” He further goes on to state that a diabetes diagnosis forces the 
patient to re-evaluate their whole way of thinking and that essentially, a patient has to 
completely readapt to a new daily way of life in order to achieve positive healthcare 
outcomes. 
“You know if you’re a new diabetic, at 75, you have to change your way of 
thinking. You can’t do what you did for 74 years - just eat what you want when 
you want. How?! You can't do that anymore! You have to change your whole way 
of life, and it took me a while to clue into that too.” – PT1 
Patients acknowledged that food choices played a role in their disease 
management. The immediate feedback of a test result forced patients to reconsider their 
food consumption habits. Patients reported improved eating habits; however, it 
sometimes meant that they needed to give up some of their favourite foods, or such foods 
needed to be consumed in much smaller quantities. PT4 indicated “I try to think of - like 
if [my sugar] is fine, I don't think about it again until next time. But if it's up, I try to 
figure out what it was that made it go up.” To add to that, PT3 stated that being 




diagnosed with diabetes made her realize that she needed to be more conscious about the 
amount of sweets she was consuming; something which she did not routinely consider 
previously. “Well [self-testing] just makes you more conscious of what you eat. And I 
mean you pay.  I'm going to say you pay for it if you overindulge. I mean, I think I never 
cared for sweets, until I got diabetes.” PT5 shared a similar sentiment with regard to his 
predilection for his favourite foods:  
“Breaded tenderloin is a really greasy thing. I love that. So I got it probably twice 
a month, but I should have it every other week [or] every once a week! But um 
no. We held to what we shouldn't eat. And let go of drinking pop. I don't drink 
much pop. I drink water. I don't drink beer. I cut myself way back.” – PT5 
Patients also reported that exercise was an important aspect of managing their diabetes.  
“You're better off to get going, because, to me, exercise is the number one enemy 
of diabetes. The more you do, the better you will feel.”  - PT1 
“Exercise has a lot to do with it, but because I have a bad back, I go - maybe go 
over to Walmart or something. Someplace like that.  I get a cart and I can walk 
around and push that, and that's my exercise. So, I think that's – you know - one 
of the good things about [self-testing]. That you can monitor sort of yourself.” – 
PT3 
The quotes shared by patients in the above section clearly demonstrated the 
reported significance of lifestyle choices in diabetes management. 
4.4.1.3. Physician Perspective on Self-Testing in Chronic Disease 
Management 
In chronic disease management, the physicians supported the concept of self-
monitoring blood glucose (SMBG) as it enables patients to be more proactive about their 
healthcare and decision-making related to their disease management, as well as providing 
an opportunity to enhance the patient/physician relationship by offering education.  
Additionally, ST provided the physicians with valuable information regarding the 
patient’s motivations as a participant in their own healthcare; they share their perceptions 
below:  
“I think it's [self-testing] important initially, because it gives people a manner of 
empowerment of control. They can see what their numbers are. Some of them, if 
they're able to cognitively make the connections between meals and lack of 




exercise and sugar readings, sometimes, there may be some behavioral change 
that comes as a result of that, in regards to their conservative treatment. As their 
disease progresses and goes on, I think testing becomes important because it 
becomes a sign of motivation for patients, because it's not fun to prick yourself 
once a day or three times a week for example or twice a day, to try and help 
manage your sugar levels together with diet and your meds and exercise” – PY1  
 
“I like the idea of blood glucose testing. I think people can get information from 
it. For instance, our local diabetes education center is telling everybody they 
should get a blood glucometer to test their sugars all the time. And many of these 
people aren't on any meds, or are just on Metformin. And there is actually zero 
evidence of any benefits in testing in those situations. Now, in my mind, it makes 
sense that somebody might learn something. You know, they learn how their 
blood sugars react individually to certain amount of exercise or certain amount of 
food, and then they could micromanage things.” – PY2  
 
“I believe [self-testing] is very important and the reason for that is, it actually 
allows patients to participate you know and take ownership; so take ownership of 
the management of their condition, for example diabetes. You know hopefully by 
self-testing, it would cause some change in behaviours if they know what those 
numbers actually are. If it's gonna cause the patient to be more compliant with 
medication, or to watch what they eat, then you know, that would probably lead to 
better outcomes. So I'm thinking yeah, so more compliance and also taking 
ownership and just being involved, a participant in care. –PY6 
 
The above quotes establish why physicians believe that ST in chronic disease 
management encourages patients to become active participants in their own healthcare.  
4.4.2. Decisions that Influence Self-Testing Behaviours in Patients 
The use of a glucometer to monitor blood sugar at home undoubtedly plays a role 
in chronic disease management. Patients reported that ST assisted their daily way of life, 
and cited convenience, increased control in their sugar management, improved meter 
technology and being active participants in their own care to seek healthier outcomes, as 
reasons why ST was so important to them. These behaviours are seen as positive 
influences that promote the act of ST. Subthemes that garnished negative attention were 
cost as a barrier to ST in the setting of diabetes and adverse experiences of ST.   
4.4.2.1. Convenience 
The act of ST in the privacy of one’s own home was noted to be quite beneficial 
for patient participants. PT3 and PT5 explain below that age, mobility and accessibility to 




local laboratories can be difficult for some members of the community, as not everyone is 
able to drive:      
“What would we do if we had to go to a center to be tested.  Like as I said I am 
74. I do drive, but I mean I'm thinking if there's lots of people who are unable to 
get to a center you know. If you live in the country, how would you manage? And 
you didn't drive? I mean, I live in town. It wouldn't be such a problem. But I'm 
still thinking that the healthcare system would be skyrocketing in expenses if we 
had to go to a center to be tested. It just doesn't make sense to me.” – PT3 
 
“Yeah. there's no problem with taking the test at all. It’s easy. It's good. And well 
anybody can do it. You know what I mean. It's not hard to do…It gives me the 
freedom of doing it when I want, and I don't have to make an appointment.” – 
PT5 
 
These quotes essentially demonstrate reasons why ST is considered to be so 
convenient. 
4.4.2.2. Increased Participation in Care 
Active participation in one’s healthcare treatment regime was reported to be a 
central aspect of maintaining positive healthcare outcomes. Patient participants shared 
why ST was seen as a valuable tool to their healthcare when it came to managing their 
diabetes:  
“I can tell you why it was important to me. I knew exactly where I was when I 
tested.  If it [glucose] was too much or not enough.  The odd time it was over; but 
it put me on the straight road.” – PT5  
“If I’m thinking oh my sugar could be low I better check, and I check. I'm 
thinking - because that's in my control. Do you know what I mean? If it's a low it 
confirms, ‘okay, now I can do something about it’. So, it’s almost a bit of a 
relief…. It puts you more in control. It lets you act if you need to.” – PT6 
These quotes suggest that ST can provide meaningful information to patients to 
further execute decisions as it relates to their health. 
4.4.2.3. Improved Blood Glucose Management 
Using ST as a tool to improve blood glucose management was seen also as a 
benefit to patient participants. Patients explained that it helped them to improve and 




stabilize their blood sugar readings, as well as provided them with more information 
about their current health status, which can be comforting.  
“Well it certainly helps me feel better knowing why I am feeling the way I am, if 
in fact it is my sugar level. It happened actually just yesterday, where I took a 
sugar pill. I couldn't understand why I was feeling the way I was. I took blood 
pressure and then my sugar level which was low. So, end result was take a sugar 
pill.” – PT6 
“Your benefit is that you can adjust yourself in what you're consuming.” – PT3 
“[Self-testing] …the odd time I would forget. Just like I forgot Monday. But it 
made my health better...It makes management perfect. I know when my testing is 
high; if I ate something I shouldn’t have. And then, well, if I don’t eat nothing 
wrong, I'm good. I feel good. And for my age I feel damn good. [laughs]” – PT5 
“Well, hopefully [self-testing] keeps you in line a bit. And this way, you check 
your sugar levels on a regular basis.” – PT8 
This research data demonstrates that patients correlate their clinical symptoms 
with their blood sugar values, and that SMBG can further improve a patients’ own 
glucose management practices. 
4.4.2.4. Facilitators of Self-Testing 
Innovations in technology have ameliorated the ST process for diabetics. Patients 
describe their experiences with the automation as well as in using glucometers with 
enhanced features below: 
“It’s all automation now. It tells you: Put the strip in. So you add the strip. And 
then you punch your finger, and then it says put blood on strip. And you know, 
you just do what it says. You get to know the routine…And then you punch the 
side of it [glucometer]. It comes up 5.6 or something. That's it. It turns off by 
itself. Then you put it back in the box, and you say I'll do that again tomorrow 
night.” – PT5 
“I just got a new meter, which I can hook up to my tablet, for Dr.ABC2. Cause 
I’m bad at writing down my numbers in a book, so she suggested this new meter. 
And it's an app. You put it on this [tablet]; when you [self-test], it’ll [the results] 
go right to it. [laughs] And then I can just go and see her, and I can bring it up. 
There it is. And it's so much better.” – PT1  




“This new machine I have tells me if I'm above target or, it doesn't say anything if 
you're below target, or at target. But it does say if you’re above target.  So, you 
sort of think about that…And what I do like about this “On Target/Above Target” 
that comes up if you’re above what you should be, it’ll tell you! It's not just left 
for you to say, ‘okay well it was you know, 10.2’, or whatever it was. It tells you 
that you’re above the target level for that particular time. And you have the three 
settings. You’ve got fasting, before a meal and after. So you have the three 
settings that you use appropriately. I like that. And they have a lot of other bells 
and whistles.” – PT3 
The improvements in meter design and automation have reportedly made 
performing, interpreting and storing self-test results, much more practical for patients. 
4.4.2.5. Cost as a Barrier to Self-Testing  
Cost was prominently disclosed to be a barrier to self-testing, by both patients and 
physicians. Most notably for the diabetic population, the cost of purchasing strips to 
perform the testing plays a role in influencing the number of times a patient is able to test 
their blood sugar. PY1 describes how the pharmaceutical industry and the government 
play a big role in affordability of strips:  
“The strips remain the drawing card for the pharmaceutical companies, because 
you have to pay for those. The government and then several other private insurers 
have recently put some boundaries on how many strips patients are allowed to use 
in a given time, which was quite controversial [as it] was received by diabetic 
folks harshly at first, but I think they’ve come to accept that that's probably a 
necessary evil in terms of funding and in terms of the reality of how many times a 
day patients really do need to test their sugars.” 
However, he further explains that the affordability of glucometer strips may create 
barriers to testing blood sugars at home. When strips are subsidized by a drug benefit 
plan, access to glucometer testing is still possible by patients, however, testing may not 
occur as frequently, as patients would run out of test strips. PY1 expressed that the 
affordability of strips is especially difficult for disadvantaged members of the 
community, further increasing the barriers to testing that those individuals may already 
face.  
“I think for people that are on ODSP (Ontario Disability Support Program) – 
which is an Ontario government funding mechanism if they are unemployed or 
don't have any other financial resources, or they’re on Trillium which is another 




benefit plan for folks who are working but don't have benefits, or they're on the 
Ontario Drug Benefit Plan for seniors – then getting strips is not a big deal. 
Because they are, I think, appropriately paid for or funded. If you are the 
‘working poor’, it becomes a lot more difficult to be able to afford to buy strips. 
And those are often disadvantaged populations that maybe do not have 
accessibility to things like ODSP and Trillium for whatever reasons…many, 
many, many barriers. Like everything, that’s the portion of folks of the population 
that testing is probably not ideally setup for yet. I’m sure there’s a big gap, and I 
see it in my own office.” 
In the patient participant group, the cost of performing glucose testing at home 
was also highlighted as a major barrier associated with self-testing. PT1 noted:  
“Because I have Green Shield coverage through [workplace] - because I'm retired, 
I still have all of my benefits.  I have heard from some of the elderly, that the 
government limits them to a certain number of strips. So they have to be careful. 
But like for myself, I can just go - I get two boxes at a time. 200 strips. About 
once every two months, maybe less.  So it does help.” 
When the researcher inquired how the cost to own, maintain and perform the self-
test, would affect their decision to perform the test, PT1 argued that it would limit the 
amount of times a diabetic would check their blood glucose levels: 
“You would limit your testing because, strips aren't cheap. They're about a 
hundred bucks, if not more, for say 90 or 100. It adds up. And when you're a 
senior – like I worked with guys, they retired years ago and their pension is quite 
a bit less than mine, and they worked at the same place. But because the rate of 
pay went up when I retired, it makes a difference on your monthly income. I don't 
want to talk figures but say they were getting $400 a month, well mine might be 
$1200 a month, because he retired 20 years before me, and then he doesn't have 
the money to go and to be buying all of these strips, if he had no coverage. [So 
you kind of have to ration your supplies]. And the government has to start to 
realize too, that these elderly people, if they’re diabetic, they need those strips. 
They need to know what's going on. Like one lady said, ‘I can't do it as many 
times as you, I'll run out of strips.’ And then the government won't do it. Then 
she's paying out of her pocket. She says ‘I don't have the money’.”  – PT1  
PT3 echoed the same sentiment, and stated:  
“Maybe the government will listen after they hear that there are people who can't 
afford to do it; that maybe more people need to be free to get these things. 
Because, in the long run, what does it lead to? It leads to more expense.” – PT3 




Although the overall cost to perform the test was perceived to be a barrier to 
glucose ST, patients indicated that they would continue to test; however, some 
individuals would consider testing less frequently if the end-user had to assume a greater 
portion of the cost to ST.  
“It's not so much the meter, it’s the strips. They get a little on the pricey side. [If I 
wasn’t covered] I wouldn't do it four times a day. I would probably do two to 
three times a day.” – PT8 
 
“I don't think it would matter. I mean, you have to do what you have to do. It's 
[diabetes] not something to take lightly, and it leads to so many health problems. 
Who wants to have their leg amputated? Or become blind? Who would? I 
mean…there’s no choice there. It is scary.” – PT3 
 
“I’m paying for the strips. I get coverage, but I still pay a fair bit for the strips...It 
would not really affect my decision to do the testing.”  – PT4  
 
“I don't think the cost would affect my decision at all. I mean if it's health-related, 
that to me is more important.” – PT6 
 
It is clear that patients believe that ST is an important behaviour which provides 
valuable information about the status of their health and that the perceived fear of 
negative healthcare outcomes is a contributing factor to one’s desire to participate in ST. 
4.4.2.6. Adverse Patient Experiences of Monitoring Diabetes with Self-
Testing 
 Although patients were generally quite content testing their blood sugar at home, 
an element of monitoring the disease which was reported to be a nuisance was the 
numerous times that patients had to prick their fingers. PT4 explained that for him, he 
only seems to self-test when he is feeling unwell, because it’s not fun to prick yourself 
every time you eat. Additionally, both PT5 and PT8 suggested that repeatedly performing 
capillary punctures was both inconvenient and uncomfortable.   
4.4.2.7. Physician Perspective on Factors that Influence Self-Testing 
Behaviours 
Although the patient participants cited convenience, increased control in their 
sugar management, improved meter technology and being active participants in their own 




care as positive reasons why ST was important to them, physicians have noted that ST is 
not always a positive experience. They share their experiences below: 
“What I've seen is, there seems to be three groups of people that I see. All three of 
them have a certain percentage of them that will test.  But Group 1, they just have 
very good sugar control, they have mild disease, somewhat slowly progressive, 
but they take significant steps to control it on their own or with medicines. The 
Group 2 are the people that are always uncontrolled. Again, where a small 
percentage of those folks, maybe 20%, will continue to test, but they seem to stay 
out of complications and they do reasonably well over the long-ish term. Now 
we're talking twenty years now of my experience with diabetes so far in practice. 
And then I see the patients who are just horribly, horribly controlled. HBA1C is 
always over 90, often over 100. Compliance with medicine is poor; eventually 
have a vascular outcome or something similar, with very little motivation to test. 
Some of those people do test, and are just resigned to the fact that their lifestyles 
are not going to change; they’re on a certain amount of medicine – they don't 
want more, or their disease for whatever reason, is just very, very difficult to 
control.” – PY1 
“I think it's kinda person-by-person basis, right? Cause we definitely see the 
opposite a lot, where people are not engaged, they don’t do their self-testing. Um, 
but some people just are motivated because they want to be better, or they have a 
worry about missing something that could be wrong”. – PY3 
“So, in some cases yes [self-testing can improve patient care]. So, again, the 
glucometer, certain selected patients will [test], some patients it will not. And 
interestingly, again the large population data suggests that twice-daily glucometer 
testing in type-2 diabetes doesn’t improve control or change outcomes. So, I 
would like to say that it does, but I think there are all those other forces that are 
preventing people from being compliant…and really [working] on their lifestyle; 
so their diet and their exercise. You know, I think it’s up to the patient. If the 
patient really internalizes, if they are really serious... they will say ‘you know 
what, I’m going to take control of this, and I do not want to be on 6 different 
medications everyday.’ Then yes, self-testing is an important tool and a helpful 
tool for them…. But on the other hand, there are people who go through the 
motions, and they maybe check a few times before they come to see me, because 
they know I’ll be asking. But they are still 120 kg in weight and they might lose 1 
kg. Like oh my goodness, I know you can do better.” – PY4 
 
Physicians essentially reported that a given percentage of the diabetic patient 
population is motivated enough to participate in their own care, while another section of 
the population is not, and that each case of active healthcare participation was unique to 
the patient.     




4.4.3. Impact of Self-Testing on Patient Safety 
In this section, patients share their thoughts regarding the training received to 
perform ST on their glucometers, as well as the perceived accuracy of the devices they 
are using to perform the testing. This is an important section, as it highlights how capable 
and experienced patients feel about the training and testing process. Furthermore, patients 
explained how their meters provided self-assurance that accurate readings were being 
displayed. 
4.4.3.1. Training 
All patient participants indicated that they were generally quite comfortable with 
the training procedure, as well as handling and performing testing with their personal 
glucometer. In the majority of cases, patients were trained by an allied healthcare 
professional.    
“The nurse showed me. It's just a matter of pricking your finger, and putting the 
tab in. Once you push the tab in, the machine comes on. You get the blood to 
come, and then you just touch [the glucose strip]. And you wait 5 seconds, and it's 
there. The training was very simple” – PT1 
“The first one I had was called a ‘Breeze’. I don't even know who made it, but it 
isn't out there anymore. The gal - well she was a pharmacist - she showed me how 
to use it. It was a very simple one.” – PT3 
“The pharmacist took it out, made me do it 2 or 3 times, and I could do it ever 
since…They just showed me how to do it.” – PT5  
“Oh, my wife. I just used to watch her, and sometimes she'd check me too. Give 
me a stab of the finger and read it, and it was always good.”- PT8 
The aforementioned data indicates that a variety of individuals were involved in 
acquainting patients to their ST devices. 
4.4.3.2. Perceived Accuracy of Self-Testing Devices 
The accuracy of ST devices is an important element of ensuring good patient care 
and optimal patient safety, as these results are used by both patients and physicians in 
clinical decision-making. Both groups reported that finger-prick glucose results 
correlated well with laboratory glucose values.  




“I trust the little meter. It’s pretty accurate with the blood lab when I go for my 
blood testing.” – PT4 
 “I went to my doctor, a week ago Friday…and I thought that my testing was 
higher than the results of my clinic test. He said mine was 6.4, and he said that 
was good. And that was about an hour after lunch.  And I thought that was pretty 
accurate…I do think that [the glucometer result] gives you some sort of 
confidence that you're around it [glucose measured by lab]…confident enough to 
go on. It's not major. It isn’t like its 15-point something, or out by that much. I 
think it's pretty accurate.” – PT3  
 
 “It's perfect. Perfect. Easy to use. It's dead on. Like you know, it don’t waver.” – 
PT5  
 
“The one I have is considerably old, but I have confidence in it.” – PT6 
 
“Well hopefully it's accurate. It's just a brand new one.” – PT8 
PT4 did remark that he had a couple of glucometers, and had noticed that one meter was 
providing readings that were not consistent with the other meters. His follow up action 
was to phone the company, who told him not to worry as the results were within 
acceptable limits pertaining to the accuracy of the device.  
“I got a couple of them there, and one’s off a little bit from the other one, so I 
called the company, and they said there’s an allowance for so much of a 
difference, and they all seem to be okay with it.”  - PT4 
Of note however, patients lacked the skills necessary to further troubleshoot their 
machines when necessary. PT5 explains that if he was having an issue with his machine 
that could not be rectified, then he would consult his physician for advice.   
“If I was having a problem with it, and I couldn't rectify it, I’d have a date with 
the doctor, and he would give me a blood test, or tell me to get a blood test... He'd 
look after me; tell me what to do. I wouldn't hesitate.” – PT5 
 
Generally, however, the glucometers were perceived to be quite accurate in 
measuring finger-prick blood glucose by both patients and physicians. 
4.4.3.3. Physician Perspective: Reliability of Patient Reported Self-
Monitoring Blood Glucose Values 
As illustrated above, patients reported feeling quite comfortable with the training 
process that they received to use their glucometers, and indicated that they were confident 




in the results being provided by their meters. Patients and physicians routinely use the 
self-reported glucose values in their clinical decision-making; therefore, the results must 
be reliable. Although the majority of patients do not have an educational background in 
clinical sciences, which would involve an all-encompassing training and understanding of 
clinical diagnostic devices, physicians indicated that they were generally satisfied with 
the glucometer results being reported by their patients, and explain why below:  
“So, if the patient arrives with a glucometer and with a logbook, I am fairly 
confident that they are doing it correctly and I can rely on those results, because 
if a patient is non compliant, then, they aren't testing; they aren’t keeping a log 
book; they aren't showing up. And so, you know, if someone shows up with 
information, I, in good faith will take that, that they are doing the testing.” – 
PY4 
“Generally, I'm quite confident. I mean, there can be some problems with some 
of the testers that require you to enter a code and if you put in the wrong code 
then it can throw things off a bit. But, you know we’re also correlating this with 
symptoms or correlating it with their hemoglobin A1C values. So, if their A1C 
and their values are completely contradictory, then I might look into what is 
wrong with the testers. But, otherwise I would assume that they are correct. 
They [the meters] are quite accurate.” – PY2 
“I think you have a better idea, like case-by-case. Knowing whether the patient 
has been taught. Knowing whether they were the kinda person who would 
follow instructions to a tee. Maybe if you did like follow-up on your education, 
having the patient demonstrate the skill of doing the test. Cause I think that's 
really what we're talking about – about whether the results are reliable, and then 
also knowing how they recorded their result; like whether they're writing down 
the numbers at the time, or whether once a week they're like ‘oh what were my 
results this week’, and they tried to recall them. Like, that makes a difference on 
the reliability of their result.” – PY3 
Physicians acknowledged compliance, patient education and relative ease of 
meter use as reasons why they believed that the results reported by patients were 
dependable. 
4.4.3.4. Physician Perspective: Interpretation of Patient Reported 
Self-Monitoring Blood Glucose Values 
An element of ST blood glucose that keeps the patient safe is for the patients to 
understand what the self-test numbers represent. Diabetic education is essential for 




ensuring that patients can correctly interpret their ST blood glucose values, and then 
furthermore, take action when required. 
“I think one of the challenges is just, making sure the patient knows what to do 
with the information and making sure they have the necessary knowledge and 
skills to be able to kinda interpret the results they're getting, and understand how 
they relate to them like as an individual patient and how those results relate to the 
management of whatever their health condition is.” – PY3 
 “So, a part of diabetic education is for patients to be familiar with what the 
numbers represent. What's normal versus not normal. So if I say to a patient, ‘for 
you particularly, I want your fasting sugars to be under 7’, and they are doing self 
testing, I am completely fine with them interpreting those kind of things, based on 
what I've educated them on. So they can know that yep, if it's between 5 and 7, 
I’m good; I keep doing what I'm doing. If it's under let's say 3 or 2, then I'm very 
low, I now need to act on this, you know eat and etc.; or if I'm very high, these are 
the things that I need to be doing.  That part I'm comfortable with…I think for 
self-testing to be an effective tool, patients need to have proper education. So that 
needs to be available to patients, to know how to interpret the results; know when 
to seek help; they understand the implications of a normal; they understand the 
implications of an abnormal reading, and again, when to show up to the doctor.” – 
PY6 
 Physicians discussed that educating patients about their health condition was an 
important aspect of correctly interpreting self-reported blood glucose values. 
4.4.4. Impact of Glucose Self-Testing to Healthcare Decision-Making 
Healthcare decision-making involves both the patient and the physician reaching a 
consensus on a treatment plan which is the most appropriate for the patient’s condition. 
For patients who complied with a ST regimen and routinely logged their blood sugar 
values, the data points provided physicians with a better overall picture of the patient’s 
glucose management. Blood glucose values measured over a series of weeks at various 
times during the day were thought to be more helpful in understanding the patient’s 
condition, than a single fasting blood glucose value drawn by the laboratory for routine 
three-month bloodwork checkups.   
“Definitely, it plays a role in decision making, because it gives me an idea... I can 
check an A1C which gives me a three-month average, but you know if it's high or 
low, I don't know where those numbers are coming from. Is that they’re waking 
up and their fasting sugars are very high? Or are they getting low at night? I won't 




know that from my blood test, because it's just for that one time when they go to 
the lab. But if a patient is tracking over the course of a week, two weeks, a month, 
and I'm seeing different readings, of course that's valuable information.  So from 
the diabetic standpoint, it's very useful.” –PY6  
“I think of self-testing for sugar the same way I do about having a blood pressure 
monitor at home. If it's accurate, and it works, it helps me. It helps them. 
Empowers them. Motivates them. Bring them into treatment ideas. Helps them 
accept their diagnosis, which is often difficult even after years. And it’s a huge 
plus to me if they remember to bring all those numbers in. Because many patients, 
particularly when we talk about hypertension, which has a subjective feel to it in 
terms of how the patient is that day, or how worried or anxious they are - it can go 
up and down with your epinephrine levels of course. Sugar doesn't do that; not as 
dramatically as blood pressure does. So home blood pressure measurements that 
are 130 on 80 at home consistently, versus my 160 on 90 because the patient just 
ran up the stairs, or they’re freaking out about their blood pressure – those 
numbers at home make my life a lot easier. It also keeps the patient safe because 
I'm not piling medicines up on them, to the extent where they stand up and get 
dizzy and fall down and break a hip. So - very helpful! Sugar is much the same” – 
PY1  
Furthermore, PY1 goes on to explain that single blood glucose values can also be 
important indicators of a patient’s health, when interpreted in the bigger clinical context 
of the patient’s medical history. This is why routine logging of glucometer readings can 
be important. 
“I don't let individuals sugar measurements change my management.  Like most 
GPs, I actually don't even test patients’ fasting sugars anymore in their 
bloodwork. I’ve run their sugar diabetes management now with an HBA1C with 
their every 3-month test. It has been shown to be more accurate for microvascular 
complication. It is done non-fasting. Its very easy. I don't send patients for fasting 
bloodwork for anything anymore, because new guidelines have come around to 
say that lipids don’t have to be checked by fasting anymore. So, rather than create 
another barrier where you have to be fasting to get your bloodwork, I let them go 
any time during the day. It's been profoundly more easy, and I have noticed much 
better ongoing results with my HBA1C management that way.  So, sugars that are 
taking don't cause me a lot of stress as a GP.  An HBA1C that’s rising in keeping 
with patients’ sugars – So if someone came to me and said they had sugar of 20 
the other day, or 22, and they've had it for three or four days, and they were 
reasonably well controlled, I know they have an infection somewhere. Something 
bad is happening. So there’s something.  I look at it that way. But that doesn't 




make me jump to double the doses of their medicine or increase their insulin or 
anything like that necessarily. I investigate as to why their sugars have suddenly 
become out of control and then look at that. But I do pay attention. I don't just 
blow off reported sugars from patients because I find that most of them are 
experienced, and I believe the numbers. I just have to make sure that I have the 
right data and the right proof to change medicine based on, just regular finger-
prick sugars.” – PY1 
ST also is seen to help facilitate the doctor’s role in providing clinical counsel. 
PY4 shares how the experience of ST can act as a safeguard for elderly patients who 
drive vehicles. She explains: 
“So, for something straightforward like glucometer testing, you know blood sugar 
testing, it's a helpful tool for education, for helping me guide what medications I 
prescribe. And um, I think about diet modification. So it can be an important tool. 
Maybe I should mention another thing for self-testing; in patients that are on 
insulin and are driving, the Ministry of Transportation is really watching, 
especially as people get older, just really watching closely to see if these patients 
are at risk of hypoglycemia, or getting in car accidents because their sugars are 
low. So, recently, knowing what the ministry is looking at as people get older, I 
will actually tell my patients, I say “Okay, you’re on insulin, you are driving, I 
want you to start checking - taking your sugar every time before you get in the 
car. If your sugar is below five, I don't want you to get in the car; you need to 
have a snack. If your sugar is acceptable, then it's in your meter and its time-
stamped. And if you get in your car and anything happens, then you actually have 
evidence to protect you.” Because if there is an accident involving a person on 
insulin, then they are at risk. You know the other lawyers are going to say ‘you 
shouldn't have been driving this could have been due to a low blood sugar’ and 
then they actually will charge the patient and they will go after the doctor as well 
for letting someone who has uncontrolled diabetes drive. So that's where having a 
glucometer with a date and time, and educating the patients about ‘every time you 
get in the car I want you to check sugar. You're protecting yourself. You’re 
protecting me. You're protecting others on the road.’ That's a real concrete benefit 
of it. So that's a positive I see.” – PY4  
For patients, an integral part of understanding and interpreting self-test results is 
readily having access to information and/or resources that help the end-user to interpret 
the test results. With home blood sugar testing, patients reported that the information and 
resources received to interpret their test results was limited. Patients reported being ‘self-
taught’ how to interpret their self-test results. 




“I don't really [access resources]. Other than the documents that come with your 
machine, and what I have read through the years.” – PT3 
[My resources are] –  I had a lot of history of diabetes in my family. If I’m really 
high and there’s something wrong, I have to go and get it checked out.” – PT4 
“I was given pamphlets with my machine. And I been told the numbers for the 
normal range - the normal range of numbers to expect, or what's acceptable. So, 
my only concern is, what if it's too high? I'm not sure what to do in an instance 
when it's too high at this point. But I've never had that problem. And I do regular 
follow up visits with the doctor.” – PT6 
“Well the resource, like I say, is my wife, my family doctor, and the pharmacist. I 
ask him questions too.” – PT8 
Although patients indicated that they may lack additional resources to interpret 
their self-test results, it remains clear that in context of diabetes, or chronic illness 
management, ST provides important information to both the healthcare provider and to 
the patient, in order to make decisions to help ameliorate the patient’s care. 
4.5. Significant Themes in Key Informant Interviews 
Interviews with physicians as key informants on the topic of ST was an important 
aspect of this study, as it helped to draw further attention to the ongoing discussion of ST 
in patient care. In this section, eight metathemes of conducting ST are identified and 
presented below. 
4.5.1. Motives to Seek Out Other Self-Tests 
Patients shared mixed thoughts on the reasons why they would seek out and 
initiate other forms of ST. 
PT8 explains that since he already routinely requires medical follow-up for his 
other comorbidities, participating in other self-tests did not interest him. He explained 
that visiting his family physician, who routinely orders and interprets his laboratory test 
results, made him feel more comfortable.  
“Well this is what I usually do; I go through him [family physician]. Plus, I got 
other health issues too and that. So this way he keeps a tab on everything… [I] 
don't know if I would do [self-testing] or not on my own. Just like I say, I go 
through my family doctor. Not too keen on it – drawing your own blood and that. 
I just feel more confident with the doctor.” – PT8 




However, PT1 suggests that more testing is better, and that if one tests more, then 
one is more likely to discover asymptomatic or hidden healthcare conditions that require 
medical follow-up. PT1 states that access to more self-tests “it can only be a positive – 
the more you test, the better you're going to know what's going on in your body, and 
that’s the most important”.  
Echoing the above sentiment shared by PT1, physicians also described why they 
believe ST is an important act for their patients, as a systematic means to be more 
involved in one’s own healthcare.  
“A patient who goes out and seeks their own testing is probably going to be a 
patient who’s like you know, wanting to be like more motivated. So motivated to 
know about their treatment options; motivated to perhaps follow the treatment 
plan that you come to an agreement on.” – PY3 
 “They're looking for hope. In my cynical days I say, in general, our society has a 
very low tolerance for any discomfort, any pain, any sense that they are not well, 
but there are a lot of worried-well. So people that have normal bodily symptoms 
that they interpret as being something wrong, and they want to find an 
explanation; like they become convinced that something is wrong, and that we're 
missing something. So, we just have a lot of anxiety and worry, and again, 
pressure that everyone is going to be happy, and healthy and pain-free. Free of 
physical pain. Free of emotional pain. All the time. That's not our reality. People 
are not good with living with uncertainty and living with any sort of discomfort. 
So when they’re uncertain and they have some discomfort, they’re going to look 
for some ways to alleviate that. And so they will spend hundreds of dollars on 
vitamins and supplements, and look for self testing” – PY4 
“I think it's important to patients because I think patients very strongly want to 
know what's going on in their body and they want to make their own decisions 
and so on. Um, and I think they also want the convenience of having their own 
testing. So I think that's an important thing.” – PY5 
 These quotes suggest that physicians believe that ST can become a patient driven 
process, as a means to identify healthcare concerns.   
4.5.2. Impact of Self-Testing on Education and Counseling 
Physicians discussed the importance of education and counseling involved in ST 
within their patient population, as patients lack the medical background, training and 
clinical judgement of physicians. PY4 states that ST “provides an opportunity for some 




shared responsibility and increasing communication and a chance to educate.” Of note 
however, PY3 points out that ST “definitely affects how you counsel the patients 
regarding their concerns.”  
 If medical advice is sought by patients either prior to or after the ST process, 
PY2, PY3 and PY5 suggests that physician involvement at either stage could help 
provide patients with much needed clinical guidance to make educated choices, 
ultimately supporting patients as autonomous individuals. In addition, the process of 
seeking out medical advice in this setting also ensures that patients become more aware 
about other potential healthcare concerns that could be related to their self-tests.  
“If a patient came to me and said I'm thinking of getting this test, or checking it or 
doing this, I would say to them that, you know they can certainly do whatever 
they wish to do. However, I would explain to them that to a major extent, there's 
the pros and cons. There's the convenience factor of doing their own thing. If they 
were able to follow the instructions and do the test, they're usually pretty easy to 
do…That being said, all my patients who do self-monitoring of their blood sugars, 
I ask them to bring in all the results so we can go over them together and I can 
help with interpretation of what the results are, and also, interpretation on how 
best to alter their medications to get them to be as healthy as possible; and the 
same thing would go with these other self-tests. If it was a matter of an HIV test, 
then I would say to them ‘lookit, we're better off doing it through the lab’ and 
‘why would you waste your money on this kit’ and so on. ‘We can do it and 
discuss it’. To me, it's a matter of them having the knowledge to make an 
informed decision.” – PY5 
“There should be some education on like why they pursued self-testing and 
whether the test is something that can be reasonably thought to be helpful for 
them, or whether it's questionable or whether the test is truly indicated. I'm not 
sure if really educating the patient is sufficient, cause you shouldn't really expect 
the general public to have the same knowledge of what kind of medical tests are 
indicated as you would of their doctor.  So I mean, I don't know if just educating 
the public is sufficient.” – PY3 
“The problem is we take away those teachable moments though. So that person 
who comes to me for their strep swab, I can explain to them that strep is actually 
bacterial and treating will make one day of difference, where if it's viral [its] 
going away on its own. And you can often treat and cure strep on your own. I can 
explain if they are coming to me with their HIV test. We can talk about the risky 
behaviour, and talk about, instead of just testing yourself for every three months 
for reassurance, how about changing your behaviour to make a difference. If 
they’re just doing this on their own, then they’re reassuring themselves, without 
actually making any efforts to change their behaviour. So it's their choice, but it 




means that we're missing out on teachable moments. I think that its going to be 
sort of a buyer beware thing, that you know, the buyer will have more autonomy, 
but they're going to miss out on the ability to make some changes.” – PY2 
 
In this section, physicians contextualized and emphasized the importance of 
educating patients in the setting of ST to make sensible and well-informed choices. 
4.5.3. Impact of Clinical Test Results to Healthcare Decision Making 
4.5.3.1 Interpretation of Self-Test Results 
Interpretation of self-test results is an important aspect of clinical decision making 
for both patients and physicians. When patients voluntarily exercise their will to 
participate in ST, they must also be ready to handle the outcome and significance of the 
self-test result. Furthermore, if patients present their doctors with ST results, physicians 
are tasked with evaluating the self-test result in the context of the patient’s history. 
Physicians explained that self-tests which have been on the market for many years such 
as glucometers, pregnancy tests, and ovulation testers were generally more reliable, and 
again, given the patient’s clinical context, it would affect whether or not the self-test 
would be repeated with standardized labs. 
“If there's things that I can't say are validated, I may need to repeat some of those 
things” – PY2 
 
“People as an example people who do pregnancy test and come to me and say 
they're pregnant, I know those tests are reliable I don't recheck them. They're 
pregnant!  If somebody used a fertility test, an ovulation tester to help get them 
pregnant, we just go with it. I mean that’s fine. That doesn’t bother me at all. We 
just run with the pregnancy at that point…As the technology evolves, as the 
quality of testing evolves, and as my knowledge of the testing quality evolves, it 
will impact whether I am repeating things or not, um, and sort of what we do from 
there.” – PY2 
“I think the urine tests are pretty accurate and pretty good, although there are 
different ones out there and they have different ranges, although most of them are 
more standardized now. In the olden days, not all pregnancy urine tests were the 
same, with the same sensitivity and accuracy. So it depends on the test and what 
they're doing, and to a major extent, I often will repeat whatever test they did. So 
if it's a urine test, we will repeat the urine test. If it's a blood sugar test – 
sometimes they'll come in and they’ll say it's high or it's 20 or whatever – when 
we do a proper venipuncture and check the blood sugar, we often find that the 




number is different than what the finger prick blood sugar shows. So, they're not 
the most accurate. So, depending on whether it would affect the change of my 
treatment plan, I would repeat things and/or order other auxiliary tests to help me 
with the proper diagnosis and proper plan – PY5 
Patients also shared their thoughts on how access to other self-tests could affect 
their healthcare. Although PT1 was quite comfortable performing ST on his glucometer, 
he indicated that when it came to performing other self-tests that are available on the 
market, he would prefer that a qualified healthcare professional complete the testing for 
him. PT1 explained that because he has routine bloodwork drawn every three months, 
any interpretation of lab test results and follow-up would be completed at the physician’s 
office, which was seen to be more beneficial for him. Patients indicted that interpretation 
of results without having more knowledge about the test or the meaning of the test results 
made them uneasy.   
“I would not want to do a laboratory test on my own. I would let somebody else 
do it; somebody that's qualified. I don’t feel I’m qualified to do that.  My own 
little meter that's fine. But like I said, I go once every three months [for routine 
bloodwork]. All the doctors get a copy... And it's so important, you know, that 
every doctor gets your result. And I can get it too. I can go online and get it no 
problem. But sometimes, just going in and going over things with the doctor, 
makes a difference. So that way, I feel it's more benefit to have a lab. You go in to 
the lab, and let them do it, rather than you do it at home. Because most people, 
will not send that result to the doctor. They’ll just keep it. I’ve been around long 
enough to know. Myself? I probably wouldn't hide it from the doctor, cause I'm 
only hurting myself.” – PT1 
A similar sentiment was shared by PT6, explaining that self-test results could be 
misunderstood by patients/consumers if they are not trained to comprehend the meaning 
of the result in their given clinical context. However, if individuals are fully informed 
about the test and what the results mean, then it allows the end-user to take action when 
necessary. Additionally, PT1 and PT6 went on to stress the importance follow-up visits 
with physicians after ST, as described below:    
 “If you want to help yourself, yes you will go and see him, and show him the 
results, and let him know, or her - what is going through your body, and what 
your body is doing. It is only of benefit to you.” – PT1 




“I think it's important. I think follow-up is good in any circumstance, especially 
self-testing, in case you're misinterpreting the results or you're looking for 
clarification of the results.  I think it is important. Yes.” – PT6 
From the patient’s perspective, ST and the ensuing follow-up with a qualified 
healthcare provider is considered to be an integral part of understanding one’s own 
health.  
4.5.3.2. Personal Electronic Access to Laboratory Test Results  
During the interview, the researcher also inquired how physicians felt about 
patients interpreting lab tests results, given the fact that they do not have a background in 
medical knowledge or clinical training. In many of these circumstances, the patients are 
conducting self-tests and interpreting the results themselves. One theme that emerged 
from this discussion was online access to patient lab test results, with physician ordered 
laboratory tests. In the following section, physicians present their thoughts about patient 
access to personal laboratory test results.  
“I do a lot of work in Urgent Care, and I see people coming into urgent care. Now 
– these people undoubtedly suffer from an anxiety condition anyways, but when 
they see a little red mark beside one of their tests, even though they don't know 
what it means at all, they freak! They run to the doctors. That is in general, not 
helpful, because if you don't tell them exactly what it is they expect to hear at that 
time – if you tell them it’s okay and they don’t believe you, and you can see it by 
looking in their eyes, they’ll go to the next walk-in clinic. It has been a disaster. 
Now, having said that, that's one side of it.  For the right patient, empowering! 
Empowering them again to look up their bloodwork and to be in charge of their 
numbers and have access to them without having to see the doctor, is awesome!  
The issue is – is there a greater benefit for empowering that group of patients than 
the increased cost to the system, when we drive a very anxiety-ridden patient into 
a walk-in clinic. Not even their own family doctor. Right? Because they typically 
don’t phone their family doc; they just run to the walk-in clinic when they see 
something red. That I think, the balance of the good and bad of that will be borne 
out after people look at those metrics I think over a few years. But from my own 
experience in my office where we’re not talking about patients running to the 
walk-in clinic running from anxiety, it's been actually, for me it's been routinely 
positive.  My patients will come in and say “yeah, yeah, yeah, I know my 
potassium was high last time…I cut off all my potatoes.” Right? Because they go 
on the internet, and it says potatoes and oranges and bananas.” – PY1 




“People come to me and they apologize. ‘Oh, you know, I know I really shouldn't 
look things up on Google.’ But I say ‘no, no it's okay if you look things up…it's 
just - I do appreciate - let's chat about it. Let’s make sure we can review.’ Cause 
you can look things up, but to actually understand the true big picture clinical – 
and even many doctors have troubles up keeping up with the evidence to figure 
out what to do about something. So it shouldn't be – you know like my diabetics 
who buy their insulin over the counter or get a prescription and just don't come to 
see me for a year or two years. I mean, that’s really not going to be good care in 
the end. You know, trying to be their own doctors?! We need to work together. 
They need to come. Let's talk about what’s the evidence; what should we be 
doing? Should they be on this medication? That medication? How high is their 
A1C? How do we need to adjust things?  Is there evidence for a statin or not? 
They have the right and I think all the power to them in looking at their own 
results, but I do appreciate you know reviewing it with them to talk about what it 
means.” – PY2  
“So I mean that's a huge challenge, and that's one that we already see quite often 
because patients already do look up their own lab results, like at some of our local 
laboratories. So we have encountered that, and patients will like call the office 
and they’ll say like ‘oh my number was this’... or you know, it'll be like outside 
the normal range, but they have no understanding of like if it's way outside the 
normal range, if it's dangerous, or if it's just possibly a normal variation or a 
variation related to their health condition, or it's something they've always had. So 
there's all those variables. Where if you have the whole context and you have the 
medical knowledge, you might be reassured by a normal lab result, or you might 
be worried by a normal lab result, depending on what the history is. So most 
patients certainly don't have that kind of background knowledge about their health 
condition. They might not know what the test is; they might not know what the 
test is looking for; and they very well might not know how to interpret a result. 
And then that can cause them either a lot of worry where they shouldn't have it, or 
potentially they might be reassured where they shouldn't be reassured, depending 
on the individual situation. So I think it's important, maybe for both doctors and 
patients to know if patients will have, like access to information like that, and just 
knowing if that’s something that’s going to affect your follow-up; kind of like 
anticipating those situations. – PY3 
 
Essentially, physicians explained that patient access to laboratory test results has 
its benefits and its drawbacks. From one perspective, patients have the right to access 
their own medical information. In the right patient, access to one’s own medical 
information can be motivating. However, depending on the patient, this can become 
worrisome. Some patients become highly anxious when they see results that are not 
perfectly within the normal reference range for laboratory test results. With the 




abundance of literature and information available through the Internet, patients can freely 
inquire why their lab test results may be out of range. This can introduce even greater 
anxiety and fear where there perhaps should not be any. Conversely, patients may be 
reassured when they should not be, by negative or normal lab test results, if they are not 
interpreting them in the correct clinical context. 
4.5.4. Impact of Self-Testing on the Patient/Physician Relationship  
The act of ST in the patient population has its strengths and weaknesses. As a 
result, the effects of ST in the general population are noted to impact the 
patient/physician relationship in various ways. Physicians expressed various thoughts on 
how ST can impact their relationship with their patients:  
“I would say by and large, self-testing has improved relationships and improved 
patient care. It gives me added information and helps me think about things that I 
have not thought about before actually… So, yes, self-testing for me facilitates 
my role as a family doc, virtually all the time” – PY1  
“On a personal level, I don't hold it against somebody, it doesn't affect my 
relationship in that sense. It only would affect my relationship if they then choose 
not to see me about stuff. So then I'm just out of the loop. And so it just impedes 
that long-term relationship. I don't hold it against them. It's just, the reality is, I’m 
not a part of the process, and therefore, we’re not building the relationship in the 
same way, and I can't be as strong or as helpful a role potentially. But I think if 
somebody is testing stuff, and when they get results, looking for next steps come 
to me, and we sort of create the plan together, then it's going to be positive...But I 
think that the piece that's lost here is, you know, me seeing them…and helping 
them out through [self-testing and self-management]; helps to build a relationship. 
So we may lose that a bit. But maybe that's just me being selfish; I like building 
those relationships.” – PY2.” 
“Definitely the monitoring that I ask patients to do - when they do it definitely 
helps our relationship. When they don't do it, obviously I feel frustrated. But 
when they do do it, it helps.”- PY3 
“I try not to be judgemental or dismissive. I’ll take that information and review it 
with the patient. And I may say, ‘What’s your understanding of this? What has 
been explained to you? What do you expect me to do with this information?’ And, 
so then depending on that, depending on what the patient's expectations are, then I 
will sit back and say, ‘Okay so, if you're asking my opinion, in my professional 
opinion, from the evidence I know and my past experience, this is what I would 




recommend.  And if you agree with the patient, if you are on the same line, that's 
okay. But, if I don't agree with what they have been told and what they expect, I 
will say that…So sometimes you do have to draw a line in the sand and say "you 
know what, I respect that you did this but, you know I will have to respectfully 
disagree with what your expectation are, and what your interpretation is". So you 
have to try and find a way to continue to maintain that patient-doctor relationship 
and work through that. But certainly I don’t –  you can’t discharge a patient from 
your practice. You can't be unprofessional. You just have to find a way to work 
with that.” – PY4 
“It's one aspect of my work which is working with the patient to let them reach an 
understanding of all aspects of their health and allow them to make informed 
decisions on how to be as healthy as they can…I think [self-testing] is helpful and 
good because I have a very good rapport and relationship with my patients, and I 
feel they can discuss anything at all and everything with me. I encourage them to 
be very active participants in their health. So I don't have a problem with it. I 
would say that it probably slows me down a little bit and so on. It's this kind of 
education that I find is most valuable, and that's how I look at myself as a 
physician/educator, so that they're educated on the body and they're educated 
about what's going on in their life, and I'm a partner in their care for themselves.” 
– PY5 
Based on their personal experiences of ST, all patient participants indicated that 
they had only really participated in the ST process with glucometers. This group of 
patients did not have very much experience performing other self-tests. However, when 
asked to describe how ST affected their relationship with their physician, all patient 
participants shared the common opinion that ST did not really affect their relationship 
with their physicians, and if it did, it was beneficial. Patients also cited that having a 
doctor that actually ‘listened’ to their concerns, instead of being rushed out the door with 
a handful of prescriptions, was an important part of relationship building.   
“[Self-testing] should strengthen the relationship. Cause he's going to tell you, or 
she, what's going on. And you should be ready to listen. Makes a difference. Cause 
it's only going to help you; in the end, that's the bottom line - helping yourself.” – 
PT1 
“He's a good doctor. A lot of people said he was a younger doctor. He's not that old. 
I don’t know, he's 55. Maybe? But he has your interests at heart. And there's some 
guys that take you in there; this, that and the other….and they just want to give you 
pills. Did they talk to you? No, they didn't have time! Well get another doctor, and 




talk to him. He always makes sure he gets in touch with you. He knows what you're 
doing.” – PT5 
“I’ve been with him. Well, he took over the practice; I was with the doctor 
before… So he's been 20 some odd years my physician. So, there's a relationship 
built up there.” – PT8    
Patients indicated that they were generally satisfied with their doctor/patient 
relationship. Additionally, the data presented in this section makes it clear that in many 
ways, the act of ST can facilitate the role of the physician in diagnosis and treatment; 
however, ST can also negatively impact the patient/physician relationship when patients 
disagree with the course of treatment or clinical advice being given by their physician 
based on self-test results. 
4.5.5. Impact of Self-Testing on the Cost to the Canadian Healthcare System 
Considering the overarching role that physicians play not only in the community, 
but in each and every patient’s healthcare plan, physicians shared their thoughts on 
whether or not ST as a healthcare intervention for health promotion and illness 
prevention behaviours could act as a tool to save the healthcare system money; their 
thoughts are provided below: 
“A lot of the times you’re going to find that a lot of the [self-testing] is repeated 
by the physician with a standardized lab. So, I'm not a hundred percent certain 
how much this is going to save money for the government. And I think if you add 
up all healthcare expenditures, be it public and private, I would think that 
probably it will quite possibly increase it. So I'm not sure if it's going to be a 
major savings.” – PY5  
“I think that unregulated testing… you walk down to the shopping plaza, and 
someone pricks your finger, and tells you your cholesterol is 6.8 –  totally, 
completely out of context for a patient, that information, out of context, out of 
environment for patients, I would say in the large majority of times is not going to 
be helpful. And when it is successful at bringing the patient to the family doc, for 
a review of their cholesterol, let’s say, or blood pressure…. that stuff that does 
bring people back to the office, it is continually frustrating and amazing, that even 
after 20 minutes, 30 minutes, sitting down in the office and discussing all that – 
with appropriate full cholesterol panel testing, and follow-up with the patient – no 
change is made to their lifestyle or to their interests. So we have spent a finger-
prick cholesterol, a full cholesterol panel and usually a kidney and a blood liver 
enzyme to go with it, half an hour of physician’s time, or an NP’s time, which 
results in billing to the healthcare system for very little measurable impact. This 




becomes very problematic! … Our current system is moving to a model of service 
rather than knowledge. Like, I'm no longer a doctor – I’m now a monkey with a 
signature… “sign this…someone said I need that…sign it” - “you actually don't 
need that” - “they said I need that - sign it” … And I think in a society like ours, 
where a large number of people still work and pay tax to support this system, I 
think that is a disaster.”  – PY1 
“Self-testing can often lead to more pressure for more testing within our 
healthcare system. Some more use of resources, more lab tests, more x-rays, 
ultrasounds, more referrals to specialists. So, it becomes patient-driven as 
opposed to physician driven.” – PY4  
One quite noteworthy comment made by PY2 makes it clear that decentralization 
of laboratory tests may shift the burden of the ST cost onto the consumer; however, the 
centralization of standardized laboratory tests to an electronic platform, called OLIS 
(Ontario Laboratories Information System) will help to decrease healthcare spending. 
Access to the electronic OLIS database allows physicians to download a patient’s 
medical records that provides them with laboratory results which were conducted 
elsewhere within the province; this one step could help save money, as physicians would 
not be duplicating laboratory tests. 
“The decentralization I think will actually increase costs. It might shift the burden 
to the individual, but will actually increase the cost, because I think some things 
will be repeated. Way more tests are going to be done. Physicians – we're being 
trained to be careful and judicious with our use of tests, and use the ones that have 
evidence. But when the public is doing this, it won't be based on that. It will just 
be based on what they can be convinced by the commercials; which commercials 
can convince them to test. So I think overall, it will actually increase the cost, take 
the burden off the taxpayer and give it to the individuals who are prey to these 
anxieties. So I don’t actually think it's going to save, and then there's going to be 
some repetition. Centralization like the lab results all going into a central 
database, where now if I find out somebody’s had a blood test, I can go to this 
OLIS, I can click on my EMR, and it downloads into my EMR. So I have less 
chance of duplication that way. I can see what's been done at this hospital, but I 
did not previously have results, and I can make sure I don’t have to repeat it. So I 
think decentralization is not going to save costs, I think centralization will.” – 
PY2 
Undoubtedly, physicians generally share the opinion that ST (not in the context of 
chronic disease management) will not save the healthcare system money; rather it may 
increase healthcare expenditures due to additional usage of healthcare resources. 




Physicians also indicate that when patients participate in ST, the process becomes more 
patient driven as opposed to physician driven, which impacts patient care and patient 
outcomes (to be discussed in the next section). 
4.5.6. Impact of Self-Testing to Patient Care and Patient Outcomes 
4.5.6.1. Impact of Self-Testing on Patient Outcomes  
Physical and emotional wellbeing are important aspects of consideration when 
allowing patients to perform ST at their own discretion. Patient safety and patient care 
must never be compromised. ST is often initiated by patients, as described above, with 
the intent and long term goals of being happier and healthier by taking a more proactive 
approach to one’s own healthcare. However, physicians indicate that an increased amount 
of ST does not always translate into improved patient outcomes: 
“I mean it would be nice to say that by empowering patients and giving them 
monitors and decentralizing [testing], that that will lead to healthier outcomes and 
save the system money. I think in reality, there's some benefit and it's probably 
lower what the models would show.  Just because humans being human, it is 
hard... It's hard to stay compliant. So, despite health promotion, education, 
availability of self testing, there are so many pressures in our society that go 
against that, such as availability of junk food, people who are sedentary, so they're 
in desk jobs, they spend all their spare time on the computer, they don't know how 
to cook, so they are eating restaurant food and fast food. Those are huge societal 
forces that go against health promotion.” – PY4 
“I know a lot of self-testing does not change patients’ outcome, unfortunately; 
behaviors and their actual hard outcomes like heart attacks or hospitalizations or 
pneumonia frequencies or exacerbations of COPD or strokes from their blood 
pressure, or blindness from their eyes from their diabetes. It doesn’t – my 
perspective from my own little world is that I have not seen a large impact on 
hard outcomes for patients. In a socially supported system, testing is great, and I 
like testing, but I think we need to be very aware in our system that testing does 
not translate necessarily into outcome improvement.” – PY1 
“You know, we can provide all the education. We can provide the health 
promotion. We have community centers around here with a low-cost or no-cost. 
We have a walking indoor walking track in Clarington, with a soccer field where 
people can go and walk everyday, inside free of charge. So, there are 
opportunities available with low-cost, low-barriers, but people have to take 




advantage of it. Like they really have to make that decision to get out of their cars 
or get off their couch.” – PY4 
 Physicians expressed that ST did not necessarily change a patient’s ‘hard’ 
outcomes, that ST may actually increase angst in an already anxious individual, and that 
societal forces and social determinants of health play a role in influencing patient 
outcomes. 
4.5.6.2. Impact of Self-Testing on Patient Care 
The process of patient initiated ST can be beneficial in some cases, as it could 
improve patient care. However, PY1 explains that these tests would have to be indicated 
as useful in the patient’s treatment and care plan.   
“I definitely think there’s potential for self-testing to improve patient care. Um. 
Like I say, patients who know their condition needs monitoring, or patients who 
are in an at-risk population who like certain test would be recommended, I mean 
the ability for the patients to initiate that test is important. And like potentially 
there's great benefit to the patients and to like public health in general for having 
that available.” – PY3 
Physicians also expressed that ST may also impact patient care if there is a fragmentation 
in the continuity of the patient’s care:    
“[ST] takes me out of the loop somewhat, which doesn't bother me per se, but I 
think can potentially hurt the patient, because it just means I don't know what's 
going on. I’m not part of that process. Same way that if they go to the walk in 
clinic exclusively as opposed to seeing a primary care physician, you know, for 
continuity of care. You’re losing out on that continuity of care if you're doing this 
sort of exclusively… I just think that the one thing that’s really, really beneficial 
about the Canadian Medical System is continuity of care, and I hope that people 
wouldn't lose on that continuity of care with a private care provider because 
they’re doing less testing.” – PY2  
 “So I think they need to have access to a family doctor. That’s the reality. 
Because lots of people offer testing and have no idea about what the context is or 
even what the next steps are, cause it's a money-maker. Its money. All kinds of 
people paying money to have stuff done, and the person doing it really certainly is 
not going to be there 10 years later to help support the patient, and probably 
doesn't understand the pathophysiology of the disease that they're looking at in the 
context of the patient either, and unfortunately the only one realistically suited to 
that task is the patient's primary care provider. Whether that happens to be a GP 
or an NP or an intern. Whatever. Whoever that happens to be. But somebody who 




understands pathophysiology of disease and can assimilate all their other medical 
problems and medicines into some kind of diagnosis and feasible plan for them – 
PY1 
Education and counseling is also an important element of good patient care. 
Patients who conduct ST need to be fully aware of the implications of ST prior to the test 
occurring and need to be ready to understand what the results mean for themselves in 
their clinical contexts. 
“The downside, how [self-testing] could affect my role as a physician, if patients 
are just interpreting those results on their own, not coming in to get further 
assessments, so they're just using whatever information they have, then that could 
probably lead to not the best care for that patient, because they have kind of taken 
the matter in their own hands.” – PY6  
PY5 shares an example of the use of home pregnancy tests to consumers within 
the general population when the test is performed without thinking of its consequences. 
“So you know, as long as patients have the ability to go and get proper education, 
proper counseling; so if you came to the Emerge or Urgent Care, and said “I think 
I might be pregnant - can I have a pregnancy test?’ Before we do the test, we 
would council you: “Okay before we do the test what would you do? What's your 
thoughts? What supports do you have? Is this a good thing or a bad thing?” It's 
much easier to talk about that when it's still a hypothetical situation, than ‘oh you 
are pregnant and now what are you going to do?’ It can make people even more 
uncomfortable. So, I can see a lot of my colleagues saying it would be better if 
they didn't have these tests out there, because people come into the walk-in clinic 
‘I’m pregnant, what am I going to do? I think I might want to kill myself’ and so 
on, because they do the test without thinking what it means and what are they 
going to do about it.” –PY5 
Physicians believe that access to a family physician to complete medical follow-
up, is an important part of the ST process. If patients exercise their right to self-test, then 
they should also be ready to consult a primary care provider who can help manage their 
concerns and support them in healthcare decision-making. Furthermore, patients may be 
harmed by the ST process if they do not have the proper support structures in place to 
guide them through the eventuality of the result’s meaning.   




4.5.7. Physician Perspective: Benefits and Challenges Faced with Self-
Testing 
4.5.7.1. Benefits 
Clearly, the benefits of performing self-testing have been shown to be numerous.   
Physicians reported that patient self-tests do sometimes present useful information to 
clinic visits. In addition, POCT has proven to be of extraordinary value with great clinical 
utility, in countries where access to healthcare resources are scarce. 
“If you're talking about like resource allocation and the time physicians spend, I 
think there's many cases where the patient being able to test themselves can bring 
you a lot more information to the encounter and like in some ways optimize your 
efficiency there.” – PY3 
“I've done remote medicine work and volunteer work in third world countries, and 
the use of point-of-care testing is a very useful and a pivotal part of doing that 
kind of medicine in a safe fashion…doing point-of-care testing when you don't 
have the availability of a lab nearby and so on, it's a huge savings, and it's an 
important comfort and it allows you to do much better medicine and so on. So it's 
a positive thing.” – PY5 
PY3 also shared her knowledge of a recently created ST program in British 
Columbia (BC) that can be initiated by patients. The clinical utility and effectiveness of 
performing self-initiated ST in this manner can potentially be of great value to the general 
public. PY3 explains: 
“I recently learned about a self-testing program in BC that's for sexually 
transmitted infections, where patients who are asymptomatic but just wanna be 
screened, can download a lab req online by entering their demographics. And I 
think it has some questionnaires, so it can like tell you what kind of test you might 
be eligible for just based on the questionnaire. And then they just drop off their 
requisition, drop off their urine sample to a lab. So there's no seeing a doctor 
involved. And like that's a kind of self-testing that I would totally support 
because, you know, sexually transmitted infection screening is one of those things 
that there's a lot of barriers to, or perceived barriers for patients. So I think, that's a 
great way to support public health and to support patients who maybe don’t have 
a doctor, or don’t wanna go or can't go, or those kinds of things to be able to be 
tested for something that is, like, you know important for population health, and 
where I think there's probably a lower risk...” 




 Unmistakably, the use of ST can contribute immensely to improved resource 
allocation and may facilitate improved community health and health promotion. 
4.5.7.2. Challenges 
ST is not without its challenges however. Physicians shared their thoughts on 
dealing with ST in the general patient population, and explained how availability of such 
tests can impact negatively on patient care. First off, physicians explained that one of the 
challenges associated with ST is ensuring that the results are interpreted within the 
clinical context of the patient. 
“I think that – like replacing Primary Care with a computer, or people doing 
anonymous test at home –  I think that’ll be a mistake, because I think our ability 
to interpret with context, like a big picture context, is important.” – PY2 
“I think there's definitely a risk of harm in over testing, and definitely I think the 
public believes that more testing is better, and the more testing you are, like the 
healthier you are and the more likely you are to catch something that could be 
dangerous. And I think there's less appreciation in the public of like the potential 
harms of testing, and the risk of like abnormal tests and a cascade of further tests, 
which might have potential harms.” – PY3 
 PY6 also notes that ST may provide the patient with false reassurance, as their 
gap in clinical knowledge may make them vulnerable to other health conditions. A 
patient’s visit to the office would allow the physician to examine other aspects of the 
patient’s health. She illustrates this thought using sexually transmitted disease (STD) 
contraction as an example:  
“If a patient is worried about say STDs, and just do an HIV self test, that's 
probably a patient I want to see in the office just to address any concerns. There 
might be additional tests that needs to be done, that the point-of-care testing 
wouldn’t do. If a patient had an unprotected sexual encounter, and they're worried 
about it, I mean HIV is just one of many. So, that’s a patient I would prefer to see 
versus encourage to self test. Is there a reason why they want to go anonymous? Is 
there something with the physician-patient relationship? Other things that I'd 
probably want to explore.” – PY6 
 Additionally, PY3 noted that an increased amount of ST would likely lead to a 
greater chance of encountering abnormal test results.  
“I guess it depends what they're testing. Cause, I guess one concern I have, if 
testing is freely available to patients rather than ordered by physicians, is like the 




risk of over testing. And then the risk of kind of like spurious results being 
received by the patient, or you know, results that don't fit the clinical picture 
being received by the patient. Or just kind of doing too many tests, cause 
obviously the more tests you do, the higher the chance that one of them will be 
outside the normal range just by chance.” – PY3 
 These are noted to be prominent themes which continue to challenge physicians 
when patients present to them with their self-test results.  
4.5.8. Ethical Considerations in Self-Testing   
4.5.8.1. Vendor & Merchant Accountability 
As self-tests become more widely available to consumers, physicians explain that 
the merchants selling the testing need to be more widely accountable for the distribution 
of the self-test devices. Such a process should or would include access to resources that 
aid in the interpretation of self-test results, as well as fair marketing practices. 
“It’s hard to just get down to what the stuff that's worth looking at, and figure out 
which stuff that is, versus all the testimonials that anybody can put, that may or 
may not be valid; …the commercialized testimonials, that we don’t know are 
commercialized, that people are basically paid to write a testimonial in favor or 
against something. So I think there is a lot of potential for abuse.” – PY2  
“If we're going to generalize it for all tests, I mean, I guess there would have to be 
some onus on the companies making these products. So, you know have this 
information available with some of these devices so that patients know what to 
do.” – PY6 
“I think my bottom line is, I think there is a lot of potential for benefit. There is a 
lot of potential for commercial abuse to the uninformed consumer, who, the 
people selling these tests, they’re expensive usually and you are preying on 
people's anxiety about things – that may or may not be a real anxiety, that should 
not have been a real concern to them. Um. Like commercial genetic testing and 
stuff like that. Sometimes you’re just going to find things that are positive, but 
aren’t really relevant, and raise people's anxieties. So we have to be careful about 
that. And unfortunately, I can’t trust the marketers to be necessarily very ethical 
about that.” – PY2 
Furthermore, physicians argued that there needs to be limitations set out on the 
availability of self-tests, as well as increased merchant responsibility for the ramifications 
of making such tests available.   




“If the patient is self-paying, then I mean, you can make all kinds of arguments 
for-or against; although like that does have some repercussions on what I say 
about follow-up. Cause I do think it's not like responsible to offer patients self-
testing, if they’re not going to have the follow-up, and that’s because they’ll have 
all kinds of results that they don't know how to interpret. So I do think if self-
testing is going to be offered, whoever is offering it has a responsibility to be able 
to follow-up with the results and to be able to monitor all the results. Cause you 
also can't trust a patient to look at the results and know if it's something that is 
fine or to know if it's something that requires follow-up – unless say they've had 
the condition for a long time and they are extremely knowledgeable about that 
individual test. But in general it's not responsible to give that responsibility to the 
patient, to know if something needs follow-up or not. And then like I say, if 
patients are self-testing and self-paying, then that does raise a huge question of 
like, are like they also paying for the interpretation of the result? Are they also 
paying for the follow-up of abnormal results? You know, and that’s all something 
that would have to be sorted out, otherwise we could be talking about large 
increases to the cost of healthcare, and questionable benefits to the patients, right? 
So, ideally you want something that's going to benefit the patients and not have 
excessive costs associated with it, rather than something that's going to harm the 
patient and have excessive costs, right?” – PY3 
 “I would prefer if we had some kind of reasonably strict regulations, that it wasn't 
marketed to people the same way that you market pills on American commercials, 
or um, or toilet paper. I would prefer it if the marketing was actually more 
responsible…So if they actually marketed it appropriately, and not 
inappropriately, and not buying into people's anxieties…If they encourage people 
to follow up with their primary care physicians, then I think absolutely; it gives 
people more control, which I think is a plus. We know that people have to take 
control of their health care, you know...So I think that appropriate marketing with 
proper rules, and you know, proper sort of follow-up, it can be – it can certainly 
be a positive.” – PY2  
 “I guess my concern is where they’re self-testing, so say something that is 
marketed online, where the person who’s offering it is going to benefit financially 
from it. So has a hidden interest - whether or not - whether the interest is open or 
hidden; that they are going to profit from the patient being told that ‘you know you 
have a deficiency in some sort of zinc or vitamin, and I mean I can sell you 
something to change that’. Even though in my mind, it's not actually clinically 
valid or clinically significant.” – PY4 




 The above section demonstrates why physicians expressed strong concerns related 
to the availability of ST to patients as consumers, as well as discussing why they believe 
that it is highly inappropriate to expect patients to be able to interpret their results and 
expect them to know if the result requires follow-up.  
4.5.8.2. Consumerism 
One theme that presented itself among multiple physicians was the concept of 
self-solicited testing which was funded by the consumer, but not necessarily prescribed 
by the patient’s primary care physician. To begin, PY2 suggests that consumerism does 
not equate to medicine:   
“I mean it happens, and it's fine, but, its just – I look at it as very similar to people 
who go to their naturopath or go to their chiropractor and get a bunch of tests 
done. The only thing I can say is that it's their power to do that, and it’s fine to do 
that, and that that’s sort of consumer’s choice, but I don't think of that as 
medicine. I think that that is more consumerism.” – PY2 
“I think a lot of the tests that they are going to buy kind of over the counter or do 
on their own are just – again – its somebody selling them a test. Whereas, at least 
when you come to a physician, I am actually not getting any advantage from you, 
sort of doing a test or not doing a test. Its based on the evidence. I am not selling 
you a product. I am not getting any advantage from it. And, so you know, I do 
think that that’s better. But people have the right to do that. Like I said, they can 
go to the naturopath, and get all these tests done, that may raise anxiety, maybe 
false reassurance, may lead to you know, sort of inappropriate or unnecessary 
treatments…” - PY2  
“Its people with more vague, undefined – "I’m tired, I’m anxious, I’m not 
sleeping, I hurt all over" – those are the ones that are going to naturopaths and 
coming back with blood tests; in some cases that I would never have ordered, but 
they have had ordered by another practitioner. I have to be careful. I have to 
respect the fact that the patient has gone there. I have to continue an open 
communication. I think if you were too judgmental, and just say that's a bunch of 
crap, then you're not actually helping improve your relationship with your patient, 
and its going to be harder to work with them. But I think there are times you have 
to say, like "lookit, I think…" - because again they perhaps have had to pay for 
those blood results or lab tests. I say ‘I think you are buying false hope. I think 
you are spending money and it's not going to improve your health, and its not 
going to change your outcome’. I will say, ‘From where I sit, and what the 




research I have done and what the evidence that I understand it to be, is that 
spending $300 on a blood test that looks at a hundred things that you’re allergic 
to is not evidence - you know is not helpful and is not going to really change 
anything’. You're walking a fine line.” – PY4 
“I feel bad saying it, but one of my experiences with that kinda situation is when 
patients go to like a naturopathic doctor, and they get like a very complete blood 
panel done, or some kind of testing which I don't really have much knowledge 
about, and I'm not really sure of the validity about. Like I had a patient who came 
with, a very very long list of potential allergens; that's happened to me a couple 
times. … A lot of times I feel frustrated in those situations.” – PY3  
PY1 also shares the story of an encounter with one of his patient’s:  
 “I have ladies have scrapes of their buccal mucosa to get their hormones done 
through the chiropractors and the naturopaths, who are having regular periods, 
which means that their hormonal access is all normal, but their buccal mucosal 
progesterone is not normal necessarily…When she had her blood hormones done 
by the OBGYN, of course they were all normal. So she comes back furious mad, 
that none of us are listening because her hormones – the naturopath told her – her 
hormones are all screwed up, that’s why she’s not feeling well. Then we're in a 
pickle. What we do? So I said ‘You have to go back to the naturopath to get 
managed for that, because I don't think I can – that's not my area’. And that's 
okay. I’m not sure that that’s professional or appropriate – but again it's the 
patient’s choice to spend their money in that regard and to believe one over the 
other, which is okay.” – PY1 
In this section, the data suggests that physicians face a number of ongoing 
challenges in their offices when patients engage in self-testing themselves or through 
other allied-health professionals and then return to their primary care provider for follow-
up medical advice.  
4.6. Summary of Data Analysis 
This chapter provided a detailed analysis of themes which emerged from both 
patient and physician interviews. Patients described their awareness of their disease as 
well as discussing the impact of ST on chronic disease management. Participants 
indicated that ST increased patient healthcare self-satisfaction and that ST generally 
helped guide food choices in a diabetes diagnosis. Additionally, patients indicated that 
factors such as increased participation in one's own healthcare, convenience of ST and 




improved blood glucose management positively affected their decision to participate in 
ST. However, the cost of ST and adverse effects encountered during the ST process were 
seen as barriers to ST. The impact of ST on patient safety was also presented. Findings 
indicated that device training and the perceived accuracy of self-test devices play a role in 
participating in ST.  
Interviews with physician participants presented thoughts as to why patients seek 
out ST, how ST impacts clinical decision making, education and counseling, how it 
affects the patient/physician relationship, the impact ST has on the cost to the Canadian 
healthcare system, and how ST affects patient care and patient outcomes. Physicians also 
discussed how the reliability and interpretation of patient reported self-test values plays a 
role in a patient's healthcare decision-making process. Additionally, the findings 
highlight physician perspectives regarding the benefits and challenges faced with ST as 
well as identifying ethical considerations in ST. This study generated new data, to be 
discussed in the following section, as well as corroborating findings suggested by other 
researchers. 
  




Chapter 5 – Discussion of Key Findings 
5.0. Introduction 
The focus of the research study was designed to address the research questions 
specified below.    
1) What is the role of patient autonomy in healthcare? How does patient 
autonomy or ability to self-manage a health condition with a self-test 
affect healthcare decision-making for both the patient and healthcare 
provider? 
2) What influences patients to participate or not participate in self-testing? 
3) Who is responsible for following up with self-test results? 
A mirrored interview guide was devised to address these research questions in 
order to capture both the patient and physician perspectives for key elements in the 
ongoing discussion of autonomy in POCT. By carrying out the research protocol, the 
researcher was able to collect and analyze data from six patient participants and six 
physician participants, to shed light on the significance of autonomy in healthcare as it 
relates to POCT. The conceptual framework devised for the research study guides the 
ensuing discussions carried out in this chapter, reflects the goals of the research study and 
describes the role of autonomy in healthcare and how it relates to the decisions that 
impact one’s motivations to participate in ST and the impact of ST on patient care and 
patient outcomes. 
5.1. Role of Patient Autonomy in Healthcare 
As previously described, respect is considered to be the underlying principle in 
patient autonomy, in which patients are supported in decision-making as it relates to the 
healthcare interventions they choose to receive or refuse (Entwistle, Carter, Cribb & 
McCaffery, 2010). In this section, we explore the role of autonomy in ST, especially in 
the context of chronic disease management.  
In diabetes, self-care behaviours and knowledge of the illness comprises multiple 
elements which includes, but is not limited to SMBG. Other significant elements include 
maintaining an active lifestyle with regular exercise, regulating food choices, being 
vigilant of illness related complications and adhering to medications as required (Toobert 




et al., 2000; Fitzgerald et al., 1998). Sedentary lifestyles, poor diet and weight gain are 
considered to be strong predictors of a diabetes diagnosis (Hu et al., 2001). Patients who 
are diagnosed with diabetes have difficulties with regulating their sugar metabolism. 
When food is consumed, it is broken down into “proteins, fats, and carbohydrates into 
amino acids, fatty acids, and simple sugars”, with glucose being the simplest form of the 
body’s fuel (Mccoy, 2009). When consuming foods high in sugar over an extended 
period of time, problematic health issues19 can arise, hence the importance of making 
healthy food choices in diabetes (HFAH, 2017).  Research studies indicate that increased 
physical activity reduces the chances of developing non-insulin dependent diabetes 
mellitus (Helmrich, Ragland, Leung & Paffenbarger, 1991; Hjerkind, Stenehjem, & 
Nilsen, 2017). In addition, Pan et al. (1997) reported that diet modification in 
combination with an exercise regimen could significantly decrease the incidence of 
diabetes in individuals with impaired glucose tolerance.   
Data collected in this research study supported the ideology that SMBG motivated 
patients to want to involve themselves more in their own healthcare and in all aspects of 
decision making as it related to their healthcare. Patients who were effective in 
functioning autonomously acknowledged that their behaviour was successful when it 
occurred voluntarily and not a result of a controlled external influence. In this study, ST 
in chronic disease management reportedly improved the eating habits of the patients and 
caused them to initiate adjustments to their lifestyles, eating habits and exercise regimes. 
The immediate feedback of the ST result played a substantial role in this scenario, as 
patients were able to assess how their food choices and exercise routines affected their 
finger-prick glucose readings. Furthermore, the immediate feedback of a ST result 
provided patients with greater peace of mind with regard to their clinical status. The act 
of ST in this context supported patients to autonomously make decisions that impacted 
various aspects of their health and well-being as it related to diabetes. Williams, 
Freedman and Deci (1998) explored a theory of human motivation, known as the self-
determination theory. In this theory, it is postulated that healthcare behaviour is 
autonomously initiated versus controlled. In autonomously motivated behaviour, 
                                                 
19 Problematic health issues: includes but is not limited to kidney disease, heart disease, stroke, as well as 
vision or nerve problems (TeensHealth, n.d.). 




individuals feel appreciative of their health outcomes when actively participating in their 
healthcare, whereas a controlled behaviour would only take place if the individual was 
pressured to participate in such a behaviour by some external force. The positive effects 
of the act of ST as an autonomously initiated behaviour in chronic disease management is 
evident in this research study as patients and physicians described their views on the 
utility of ST in the management of the disease. In this research study, patients shared the 
sentiment that the act of ST was self-initiated, with no external influences, to monitor 
blood glucose results in order to obtain valuable clinical information. Additionally, 
physicians explained that, in their experience, patients who were able to make the 
connection between food choices, exercise, and blood glucose values were generally 
more successful in keeping their illness and related comorbidities more in control. 
Research conducted by Williams, Freedman and Deci (1998) provided strong support for 
the self-determination theory. The researchers established that when individuals 
participated willingly in their own healthcare interventions, in the context of diabetes 
chronic disease management, they experienced a greater sense of ownership of their 
healthcare. As a result, patients were able to maintain their glucose levels within a 
healthier range for the long-term. The concept, understanding and utility of ST in chronic 
disease management shared by the patient and physician participants in this research 
study agree with the self-determination theory posited by Williams, Freedman and Deci 
(1998). 
Additionally, although some self-initiated self-tests can provide valuable clinical 
information to physicians, physicians continue to be judicious about the tests that they 
order as healthcare expenditures in Canada continue to grow. The Canadian Institute for 
Health Information reported that in 2016, total health expenditures were estimated to 
reach $228 billion dollars, a figure which represents approximately 11% of Canada’s 
gross domestic product in 2016 (CIHI, 2016). Entwistle et al. (2010) explain that 
supporting patients in making autonomous decisions can be a sensitive matter. If 
physicians are more prone to offering and allowing choice rather than facilitating a 
dialogue that allows patients to make informed decisions, the principle of autonomy can 
fail in protecting individuals who are considered to be otherwise competent but find it 
difficult to choose between healthcare interventions. These patients may lack a strong 




sense of confidence, or may be unsure about what treatment options are more preferable, 
or may perhaps blame themselves if their outcomes are poor. In these situations, 
Entwistle et al., (2010) suggest that patients may not feel autonomous at all, and rather 
they end up feeling abandoned as they must choose a healthcare intervention offered to 
them by their physician. This is why the patient/physician relationship is so important. 
Patients need to trust that their physicians are providing the most appropriate advice for 
the patient’s optimal health. Patients who experience positive relationship building with 
their physicians are more likely to trust in their judgement and their clinical advice. 
Pearson and Raeke (2000) explain that, theoretically, patient trust enhances the 
patient/physician relationship and, as a result, patients are more likely to be satisfied and 
have greater compliance with treatment regimens. 
5.2. Decisions Which Influence Participation in Self-Testing 
As previously described, the HBM functions to explain health behaviours 
independently or in combination from four different angles: perceived seriousness, 
perceived susceptibility, perceived benefits and perceived barriers. These health 
behaviours are influenced by measured variables in the clinical governance framework: 
risk management, clinical and cost-effectiveness, and patient outcomes.   
Risk management is an important aspect of the ST process. In this research study, 
patients reported that they were generally quite content with their glucometers and 
perceived the meters to be quite accurate. Although SMBG is known to be a relatively 
safe process, patients did not know how to initiate troubleshooting procedures, nor did 
they share if they were aware of the potential for pre-analytical, analytical or post-
analytical errors in the testing process. Additionally, only two of the six patients reported 
that an allied health professional made sure that they were competent to perform the 
testing on their own, and one patient reported that he solely relied on his spouse for the 
instrument training. Research in healthcare environments has indicated that deficiencies 
in training practices, lack of internal quality control and inconsistencies in calibration 
procedures were all points within the total testing process where the risk of introducing 
errors was more pronounced (du Plessis, Ubbink & Vermaak, 2000). Healthcare 
environments are subjected to standardized procedures and regular competency audits; 
such a process in risk management makes it easier to account for additional training and 




follow-up procedures as necessary. ST in homecare environments are not currently 
subjected to standardized procedures or competency audits to monitor risk management, 
and patients may experience harm as a result.  
The clinical and cost-effectiveness portion of the clinical governance framework 
and the HBM guide the next portion of this discussion. In the context of chronic disease 
management, the results of this study make evident that healthcare autonomy plays a 
significant role in guiding patient decisions to participate in ST. Patient participants in the 
research study reported that ST motivated them to actively participate in their own care, 
as it was feared that lack of participation may ultimately lead to worst-case scenarios in 
their disease progression. Here, the HBM supports the ideology that explains that 
participating in ST stems from the perceived seriousness and perceived susceptibility of 
the disease. The HBM also supports the construct of perceived benefits, as diabetic 
patients listed numerous examples in which ST was beneficial to the management of their 
disease. Finally, patients discussed the ways in which ST might be seen as a health 
behaviour that sheds light on the perceived barriers or challenges that they face in 
adopting such a healthcare intervention. When this same group of patient participants 
were asked if they would consider participating in other self-tests that were available on 
the market, a mixed response from patient participants was received. Diabetic patients are 
constantly in contact with members of their healthcare team in order to receive care as it 
relates to their illness. They are subjected to routine laboratory tests and follow-up visits 
with the appropriate physician/specialist. Thus, patients reported that any healthcare 
concerns that they have would be brought up at their routine clinic visits, and that any 
laboratory testing that would be required could be ordered by the physician at that time. 
This, in turn, meant that patients did not have to pay out of pocket to perform ST as there 
was a higher likelihood that the blood tests would be covered by the Ontario Health 
Insurance Plan (OHIP). Patients also explained that they felt more comfortable leaving 
the interpretation of test results to their healthcare provider. One patient however did 
express that the more one tests, the more knowledgeable one becomes of one’s own 
health. Physician participants were also of the opinion that when patients are interested in 
participating in various self-tests, they are often more willingly involved as participants 
in their own healthcare.  




This study's use of the clinical governance framework and the HBM help to 
explain the healthcare behaviours exhibited by the patients. In order to contextualize 
these health behaviours, we must understand the role of health promotion, community 
health and the social determinants of health in affecting such behaviours, which 
ultimately influence decision-making as it relates to ST.   
5.2.1. Health Promotion and Community Health 
O’Donnell (2009) explains that health promotion is a science in which individuals 
are encouraged to achieve a state of optimal health by maintaining a balance of physical, 
emotional, social, spiritual, and intellectual health (Appendix N). In general, health 
promotion is an important aspect of health maintenance, and in chronic diseases such as 
diabetes, the significance of health promotion becomes quite apparent as patients require 
increasingly greater amounts of interactions with a team of healthcare providers in order 
to manage their illness. MacQueen et al. (2001) explain that an important determinant of 
health outcomes is the context of a community. The authors suggest that public health 
programs defined at the regional and national levels are set to have prevention and 
interventions take place at the community level. Thus, community collaboration is 
considered to be an important approach for effective community health programs. In the 
context of chronic disease management, as well as the need to provide enriched 
accessibility of community health interventions to the general population, there needs to 
be greater emphasis and education placed on the importance of available community 
based healthcare programs which have been created to assist in health promotion. One 
physician participant in this study clearly indicated that although opportunities for health 
promotion with low-cost and minimal barriers may be available, patients still need to 
make a conscious effort to be active participants in managing their health. Therefore, it is 
important to understand how the social determinants of health (SDH) play a role in 
influencing decision-making in the patient population, when considering ways in which 
achieving optimal health can be attained.  
5.2.1.2. Social Determinants of Health  
Chronic illnesses such as diabetes are largely affected by personal lifestyle 
choices such as diet selection and inclination to participate in exercise. Cloninger (2013) 




argues that these variables are seen “as expressions of personality traits that are partly 
unconscious and hence resistant to change”. Additionally, Cloninger (2013) suggests that 
the SDH, elements that are not within an individual’s control, can also play a role in 
influencing poor lifestyle choices. Annandale & Field (2007) explain that the interaction 
and intersectionality of social structures, material factors, and biology affect the 
individual behaviours that guide the lifestyle choices that ultimately produce health 
inequalities as a consequence of one’s social context. Therefore, in order to address these 
challenges, community health and health promotion has become progressively more 
important, more patient-centered and more focused on generating interventions “that 
promote change in complex biopsychosocial systems, rather than attributing effects to 
causes that are highly interdependent on contextual influences. Effective health 
promotion for chronic disease needs to consider a person’s individual, familial, social, 
political, cultural, and spiritual context” (Cloninger, 2013). 
Furthermore, it is clear that the diabetic population, especially those who are 
aging, need access to ST in order to monitor their condition. According to the PHAC 
(2011), a diagnosis of diabetes proportionally increases with advanced age. In the year 
2008-2009, Canada-wide statistics demonstrated that the greatest increase in the 
prevalence of diabetes occurs after the age of 40, with the highest proportion of 
individuals diagnosed with diabetes being aged 75 to 79 (PHAC, 2011; Appendix O). 
Population data indicates that Ontario has the largest population, accommodating roughly 
40% of the Canadian population, with the majority of the population residing in urban 
areas; the province of Ontario is thus proportionately home to the largest bracket of 
individuals in the 65+ age range (Mercado, Páez & Newbold, 2007). One must consider 
how the SDH such as employment, income, social environments and social support 
structures play a role in health promotion, community health and supporting diabetics as 
autonomous individuals. Research indicates that the elderly population is highly 
dependent on private automobiles for their transport, but also the elderly tend to make 
less trips outside the home (Mercado, Páez & Newbold, 2007). Thus, there is a clear need 
to ameliorate the accessibility of ST, so that as individuals with diabetes continue to age, 
they do not need to leave their home and travel to a clinic to be tested. This highlights the 
importance of having a glucometer and a plan for the affordability of glucose test strips. 




Additionally, both physician and patient participants in the study shed light on immense 
costs related to ST, as clinical and cost-effectiveness is an important aspect of ST. In 
2009, the Canadian Agency for Drugs and Technologies in Health (CADTH, 2010) 
reported that there was limited utility in SMBG for patients who were not dependent on 
insulin to manage their diabetes. By 2013, the Ontario Ministry of Health and Long-Term 
Care introduced a limit on the number of strips allowed (on a weekly basis) to perform 
ST, in order to help control costs incurred to the healthcare system. One physician 
explained that members of the community who are the ‘working poor’ face increased 
challenges in obtaining test strips and often they are members of an already 
disadvantaged population for whom testing may not be ideally set up for yet. One patient 
also made reference to the fact that although workplace pension plans do help with the 
cost to purchase test strips, not everyone can afford to purchase the strips. Public funding 
mechanisms such as the Ontario Drug Benefit, Ontario Disability Support Program and 
Trillium Benefit can help to subsidize the cost to purchase glucose test strips to some 
extent, however, individuals who are denied these benefits or those individuals who do 
not have access to a suitable pension plan or a retirement savings fund will undoubtedly 
suffer by not being able to perform their ST. Mancuso (2010) explains that for uninsured 
individuals, socioeconomic and other demographic factors may be thought to be barriers 
in diabetes management. Additionally, the availability of resources alone may not always 
be the ultimate deciding factor in managing a chronic condition such as diabetes; social 
and psychological factors may play a role in impeding a successful SMBG regime 
(Mancuso, 2010). Therefore, there is great importance on stabilizing patient blood 
glucose readings, as patients who successfully manage their sugars are more likely to 
achieve a better quality of life, and are less likely to become an added burden of costs to 
the healthcare system. 
In summary, results of this research study indicated that one’s decision to self-test 
was influenced by several factors that were viewed in a positive manner, namely the 
convenience of ST, active participation in one’s own healthcare, improved glucose 
management, and other elements that facilitated the act of ST.  Patients in this study 
indicated that ST provided the convenience of performing the testing in the comfort of 
their own homes, not having to travel to a clinic to be tested and having the freedom to do 




the testing whenever they wanted. The testing was considered to be a valued tool to aid in 
the stabilization of their blood glucose values and the management of their condition 
because it motivated them to make better decisions so that their health would not be 
compromised. Factors that discouraged the act of ST included cost to perform ST and 
adverse effects of ST. Although the cost to perform the testing sometimes acted as a 
barrier to ST, patients indicated that they wanted to continue to test as they believed it 
was important to their health management. The examination of the HBM and the clinical 
governance framework shed immense light on healthcare behaviours exhibited by the 
patients and their decisions to participate in ST. Moreover, it is evident that choices to 
participate in ST are shaped by greater societal forces and contextual variables, which are 
elements that are not personally within an patient’s control.  
5.3. Accountability in Self-Testing 
The data presented in this research study suggests that when patients participate in 
ST in the context of chronic disease management, accountability in following up with 
self-test results is somewhat more regimented and the responsibility is shared between 
both the patient and their healthcare provider. Patients who were compliant with their ST 
and strived to attain and maintain positive health outcomes, provided their physicians 
with valuable clinical data to monitor and treat their patients. Conversely, when patients 
did not participate regularly in ST and lacked the motivation to improve their health, 
physicians were tasked with providing additional ongoing education to their patients on 
the importance of stabilizing blood glucose values in order to improve health outcomes.   
When patients in this study were asked about initiating and engaging in other 
forms of ST, patients were generally less knowledgeable about the testing process and the 
interpretation of test results. Additionally, physicians suggested that patients do not have 
the appropriate medical knowledge required to make clinical decisions that could affect 
their health status both immediately and in the long term. Therefore, patients may not 
receive the appropriate follow-up or treatment.     
Accountability in ST needs to be further understood and should be considered to 
be a long-term goal in improving healthcare delivery and patient safety. Therefore, the 
researcher of this thesis suggests that a chain of accountability be created whereby each 
link in the chain is responsible to some extent for ensuring that ST does not harm the 




patient. The chain of accountability is discussed in more detail as a recommendation in 
section 5.4.2. 
5.4.  Recommendations 
5.4.1. Looking Ahead: Is a Chain of Accountability Appropriate? 
According to Deber (2014), accountability is multidimensional; it consists of 
financial, performance, and political/democratic indicators. Deber (2014), explains that a 
more distinct understanding of what is meant by accountability means identifying what is 
one accountable for, by whom, to whom and how is one considered to be accountable, 
and finally how measures of accountability are linked to a set of concepts in which 
rewards are identified and punishments are enforced when outcomes are not met. 
Accountability for ST in the community should involve a community-based approach. 
This requires the involvement of key stakeholders within the community including with 
physicians, nurse practitioners and various allied health professionals to form a 
partnership with patients and organizations which advocate for patient safety in 
healthcare, in order to strengthen accountability in ST. By considering the variables 
which affect accountability in ST, short term and long term goals need to be identified 
and policymakers need to consider how to effect such goals.  
Additionally, accountability and patient care for self-initiated tests needs to be 
further defined and the makers of self-tests need to take a greater responsibility for 
ensuring that self-test results are met with an appropriate follow-up. There needs to be 
increased education and a greater overall awareness that patient-initiated ST is a form of 
consumerism. In order to meet such expectations, the researcher of this thesis has 
suggested the creation of a chain of accountability, in which four links in the chain of 
accountability are identified: vendors, merchants, consumers and physicians (Appendix 
P). When clinical diagnostic tests are made available to consumers, the vendors of the 
diagnostic tests need to be at the forefront of the chain of accountability. They have a 
significant ethical responsibility to ensure that if they are making these items available to 
consumers, that the tests are to be used in a safe and responsible fashion. Next in the 
chain of accountability are the merchants who distribute clinical diagnostic tests. 
Merchants need to ensure that self-tests are only available to the portion of the population 




for whom the testing may be truly warranted, as there is a greater chance of causing harm 
to the patient if testing is not conducted for the appropriate indications. The next link in 
the chain of accountability is consumers. Patient autonomy plays a significant role in 
one’s choice to participate in ST, and a variety of reasons may exist for why patients 
choose to participate in ST. One such reason is wanting to understand more fully what is 
going on in their body, and how they can help themselves to achieve healthier and 
happier health outcomes. Consumers are accountable to the merchants and vendors, by 
making a well-informed choice to participate in a self-test. Consumers are also 
accountable to themselves and to their healthcare providers to fully acknowledge the 
ensuing test result, and initiate medical follow-up as required. ST is of no benefit to the 
patient if the results are not interpreted within the correct context or followed-up with, in 
a timely manner. The final link in the chain of accountability is primary care providers. 
Physicians are accountable to both their patients and to the vendors of self-tests. It is the 
responsibility of these medical professionals to ensure that self-test results reported by 
patients receive a fair evaluation and follow-up. Physicians can be considered advocates 
for patient safety, as they play a role in education and counseling in medical practice. If 
physicians find that self-tests are being marketed unfairly or with deceptive practices, 
then they too have a responsibility to advocate against the availability of such tests. 
However, because self-tests are also a valuable and useful tool in healthcare, vendors 
need to work with physicians to ensure that clinical tests are used appropriately in the 
right context. Vendors also need to make sure that the merchants who sell the tests, 
participate in fair marketing practices and that the self-tests do not fall prey to consumer 
anxieties. The chain of accountability becomes a cyclical process, in which each link in 
the chain is responsible to some form of accountability, both forward and backward. 
Accountability in POCT does not solely rest on the vendors of POC devices. 
Pharmacies are another key player in the discussion of accountability in POCT. In 
chronic disease management, pharmacists have the chance to be at the forefront in the 
prevention and management of diabetes. In a pilot study conducted by Papastergiou, 
Folkins & Li (2016), testing for hemoglobin A1c at the POC by pharmacists revealed that 
pharmacists have an increased opportunity to identify patients who required further 
clinical intervention based on their hemoglobin A1c result; such interventions included “a 




discussion of the patient's A1c, communication with the physician, device (blood glucose 
monitor) training, lifestyle counselling, dietitian and physician referrals, and booking a 
follow-up appointment with the pharmacist”. This exemplifies how accountability to 
patients at a community-based level, is an approach which is useful in POCT.          
5.4.2. Long-Term Goals: Models for Safe and Effective Delivery of Self-
Initiated Testing 
As we look ahead to the recommended models for the safe and effective delivery 
of self-initiated ST, it is imperative that we understand the role of pharmacists within the 
community, especially as the scope of practice for pharmacists continues to expand. 
Pharmacists are allied health professionals who play a key role in providing health 
promotion to patients, collaborate with other healthcare professionals and key 
stakeholders in the pharmacy industry, and refer patients for appropriate medical advice 
where necessary (WHO, 1998).  Pharmacists are frontline healthcare providers who have 
the ability to guide self-testing options in POC. One suggested element to regulate the 
availability of ST could be as simple as moving the clinical tests to an ‘over-the-counter’ 
model, where patients who were interested in purchasing selected self-tests could 
purchase them at a pharmacy if they met the criteria to perform the test. In this scenario, 
pharmacists become the first point of contact for patients, to ensure that conducting the 
self-test is truly indicated for the patient. A pharmacist’s comprehensive training in 
medical life sciences makes them an invaluable partner in this model for delivery of 
POCT.  
Another long-term goal that could prove to be beneficial for the safe and effective 
delivery of self-initiated testing could be modeled after a pilot program that offers online 
testing services for sexually transmitted infections (STI) in British Columbia, Canada. In 
this pilot program, residents living within selected areas of British Columbia have access 
to safe, confidential and reliable tests to screen for STI’s. According to the Vancouver 
Island Health Authority (2016), patients interested in being screened for STI’s such as 
chlamydia, gonorrhea, syphilis, HIV and hepatitis C, simply need to download an 
electronic requisition and answer a few questions on the requisition. Next, they provide a 
clinical specimen to one of the participating laboratories; participants are then notified 
when test results are available. If all results are negative, the results are released to the 




patient and may be viewed online with access via a personal password. If test results are 
either inconclusive or positive, the patient would be contacted by a nurse so that follow-
up and appropriate treatment can be initiated. This is an excellent example of a 
community health program that supports population health by removing selected barriers 
to clinical testing and treatment. Although this particular scenario does not involve the 
use of self-test devices, it mirrors the concept of upholding patient autonomy by 
supporting a patient’s desire to conduct a clinical laboratory test to obtain more 
information about one’s own health status. Elements of confidentiality or even the 
patient/physician relationship, may be factors which steer some individuals towards self-
testing in the first place. Using the existing model in British Columbia, a privately funded 
or publicly overseen program could be created which would provide laboratory-quality 
testing and could act as the link to initiate follow-up medical advice where it is necessary. 
In order to determine which lab tests patients are eligible for, a screening procedure with 
a questionnaire could be developed. To avoid increased costs being absorbed by the 
current healthcare system, consumers would bear the cost of the service, as they would be 
performing the testing for their own satisfaction. If such a program were ever to become 
privatized, there would also be a greater likelihood of improved turnaround times, as 
consumers would be paying for a service directly. This type of model would ensure that 
laboratory test results are interpreted with the correct clinical context, that patients are 
encouraged to follow-up with a primary care physician where necessary and that extra 
clinical investigations are not ordered as a result of improperly interpreting self-test 
results reported by patients. 
5.4.3. Short-Term Goals 
Patient care and patient outcomes in ST are important. One recommended short-
term goal is to place a much greater emphasis on thorough training of self-tests and self-
test devices. This would ideally include a comprehensive seminar on how to troubleshoot 
faulty POC testing platforms, as well as providing end-users with greater access to 
material to help them assess the validity of results being reported. Patients need to be 
educated further about the importance of calibrations, quality control material and factors 
that can affect self-test results. A mechanism or process by which end-users can 
participate in some form of external quality assurance and competency checks, ideally 




once or twice per year, could also be of benefit to patient care, although this would 
undoubtedly increase costs to an already burdened healthcare system. Additionally, it is 
suggested that policymakers develop a quality framework to address the safe usage of 
self-tests outside of regulated healthcare environments, to ensure that clinical diagnostic 
tests are used safely in clinical decision-making.  
5.5. Directions for Future Research 
This study provided an opportunity to examine the current state of knowledge of 
the role of autonomy in ST and the clinical decision-making processes that arise as a 
result of ST. Safety guidelines can always be improved to provide greater protection to 
patients/consumers. In order to strengthen best practices and improve an optimal 
experience for healthcare delivery, further research is required to establish and enforce a 
minimum set of safety standards, which are both stringent and rigorous, in patient-driven 
ST. It is imperative that quality goals be defined, as this is an important concept in 
establishing and improving safety in ST. The establishment of a set of quality goals will 
certainly help to increase the reliability of self-test results, and will hopefully decrease 
costs placed on the healthcare system, as a result of unsafe or unstandardized ST 
practices. Additionally, it is recommended that the economic impact of the availability of 
decentralized laboratory tests in Canada, also be studied, in order to ascertain whether ST 
reduces or in fact increases, costs related to healthcare delivery. A smaller scale 
community level pilot study could be launched to evaluate this area of research, with a 
larger provincial or Canada-wide study following afterwards.     
Additionally, two long-term recommendations suggested by the researcher 
include the creation of a chain of accountability and alternate models for safe and 
effective delivery of self-initiated ST. In order for either of these models to be successful, 
several political and financial obstacles will need to be overcome in order to bring these 
recommendations to fruition. Research, planning, development and inter-professional 
collaboration will all be required. It is suggested that future research look at how models 
of healthcare delivery have changed over the past century, and how public policy and 
healthcare policy guide measures for successful community health interventions. 




5.6. Study Strengths 
In the past, many scientists considered case study research unfavourably, as 
researchers who used the case study methodology were not organized, their work lacked 
focus, did not follow a systematic procedure, and allowed biases to contaminate their 
research findings (Yin, 2009).  In this research endeavour, the researcher stayed focused 
and organized and ensured that a methodical case study informed approach was used, 
following the teachings from Robert Yin’s case study methodology as a guide.  The 
researcher in this qualitative research study succinctly presented the research evidence 
obtained and all evidence was systematically reported. This ensures that the reader can 
confirm on their own, that the research findings emerged from the data and experiences 
of the research participants, rather than from any bias or subjectivity of the investigator 
(Ponelis, 2015). Multiple iterations and revisions of the thesis have ensured that the paper 
is well written paper and findings are presented with focus and clarity. Additionally, the 
researcher had several other readers challenge the document with alternative views and 
opinions in order to achieve a well-balanced and well-written paper. The insight brought 
forth from multiple readers helped to improve portions of the research paper which may 
have lacked focus or were inarticulate. In order to enhance the trustworthiness of the 
findings, the researcher created an audit trail to document each research step taken from 
the start of the research procedure to the end of the completed research thesis. 
Hodkinson and Hodkinson (2001) also explain that a researcher’s expertise may 
raise doubts about their objectivity in the research. The primary researcher’s knowledge 
of the medical laboratory services sector is a key element of this research endeavour. This 
knowledge facilitated the creation of the goals of the research study. Furthermore, the 
researcher’s experience in health sciences research helped to generate interview questions 
that ultimately facilitated answering the goals of the research endeavour. As a qualitative 
researcher, the researcher ensured that the data being presented was continuously 
scrutinized to understand its significance as it relates to the phenomenon of interest. The 
researcher controlled for bias by adhering to data collection protocols; all data was 
collected on an audio recording device, which was then transcribed by the researcher, and 
furthermore, research participants had a chance to read a copy of their transcript to ensure 
that an accurate interpretation of their interview data was made. In qualitative research, 




this is known as ‘member checking’; a procedure which serves to ensure that 
interpretations and conclusions are made accurately and furthermore serves as a 
technique to establish validity, by giving participants a chance to read their own 
interviews (Cohen & Crabtree, 2006; Tobin, 2010). Additionally, the triangulation of 
perspectives (patient and physician) on the same issue further validated the meanings 
brought forth from the data. These measures all verify that data collection and analysis 
was impartial and unbiased. 
5.7.  Study Limitations 
A limitation of this qualitative research study is that the findings are not 
generalizable, as is seen in traditional quantitative research (Hodkinson & Hodkinson, 
2001). No attempts were made by the researcher to generalize the findings to other 
populations within the province of Canada, or even around the world. The researcher 
fully acknowledged that the data was collected from a small pool of research participants. 
As the data is non-numerical in nature, there is no way to ascertain that the sample was a 
typical representative sample of the larger population.  
In order to homogenize data collection questions, two distinct groups of research 
participants were sought. Data collection from patient participants was targeted to only 
glucometer users. This however, completely excluded individuals who may have had 
experience with other POC tests. Each end-user of self-tests may bring with them very 
different and distinct experiences of conducting tests at the POC. It would be preferable 
to capture the ST experience of patients who have used devices/self-tests other than 
glucometers.  
Likewise, physicians may also may also encounter a variety of experiences in 
their profession, and consequently may have different views of patient initiated ST. 
Ideally, physicians across Ontario, or even within a cross-section of Canadian provinces 
would have been suitable for the study, however, this was not a feasible option for the 
scope of the Masters thesis. Capturing the views of ST from other allied healthcare 
providers who are familiar with ST could also prove to be beneficial. This would include, 
but is not limited to registered nurses, respiratory therapists, pharmacists and paramedics. 
Nurse practitioners are another group of healthcare providers who have prominent roles, 
especially within community-based settings. It would be ideal to capture their perspective 




as well, as they function autonomously to “diagnose, order and interpret diagnostic tests, 
prescribe pharmaceuticals and perform specific procedures within their legislated scope 
of practice” (Donald et al., 2010). 
The views of all of these participants would be extremely useful to expand on the 
debate of autonomy in healthcare, and furthermore, would add value to the discussion of 
patient safety and healthcare decision making when ST is self-driven. This would be 
considered a large scale study, well beyond the scope of a master’s thesis. 
5.8.  Concluding Summary 
This qualitative research study provided a unique opportunity to reflect on the 
utility of patient-driven ST, from both a patient and physician perspective. The study 
shed light on the role of autonomous behaviours in ST, accountability in self-initiated ST, 
and further explained how healthcare behaviours are affected by the need for ongoing 
health promotion and community health. The study acknowledged that within pre-
established healthcare settings, measures of accountability were well developed for the 
use of diagnostic POCT, however, the lack of a defined set of standards outside of such 
settings drew significant attention. Patient autonomy in healthcare continues to face 
ongoing ethical challenges, especially as the landscape in healthcare, technology and 
newly emerging bacteria/viruses and illnesses put pressures on our healthcare system. 
Additionally, the researcher suggested both short-term and long-term goals that could 
prove to be beneficial in supporting patient safety.  Firstly, increased end-user training, 
along with more education and a purposeful focus on the development of a quality 
assurance framework, would undoubtedly be of benefit to patients and to the healthcare 
system as a whole. One long-term goal that is suggested is the creation of a chain of 
accountability as a basepoint for engaging in the discussion of autonomy as it relates to 
measures of accountability in patient-driven ST. Furthermore, regulation of ST outside of 
accredited healthcare facilities is crucial to ensure the promotion of a culture of sustained 
community engagement and patient safety. Another long-term goal involves a revision in 
the practice of accessibility of self-testing to consumers. This long term goal involves 
either moving self-tests to an ‘over-the-counter’ model, where clinical tests are only 
available where indicated, or conversely, the creation of a public or privatized online 
testing service.  The execution of any such goals requires ongoing funding, infinite 




amounts of research and an interdisciplinary approach that connects multiple key players 
in the healthcare sector in the quest to promote patient safety. The findings of this study 
suggest that the dialogue on the role of patient autonomy in healthcare needs continued 
analysis, and perspectives need to be re-framed in order to understand how the evolution 
of change affects patients, physicians and society as a whole.   
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Research area Point of Care Testing 
Research topic Managing a chronic disease using a point of care test 
General Research 
Questions 
What factors are considered in the relationship between 
glucometer usage and chronic disease management? 
Specific Research 
Questions 
What is the role of healthcare autonomy in influencing 
decisions to use a point of care test to manage chronic 






Refer to research questions listed in Appendix J & Appendix L 
Adapted from Punch, K. F. (2006, p. 21). Developing effective research proposals (2nd 








D. Appendix D - Patient Recruitment Poster 
  




E. Appendix E - Patient Letter of Invitation 
  




F. Appendix F - Physician Letter of Invitation 
  




G. Appendix G - Letter of Consent 
 
















H. Appendix H - Thank You Letter 
 




I. Appendix I - Physician Survey of Demographic Information 
  




J. Appendix J - Physician Interview Guide 
 









K. Appendix K - Patient Survey of Demographic Information 
 










L. Appendix L - Patient Interview Guide 
 
























Begin Patient and 
Physician Recruitment






July 11, 2017 
Draft Thesis Completed
November 03, 2017




December 18, 2017 
Submission of Thesis to 
Office of Graduate 
Studies




N. Appendix N - Health Promotion Matrix 
 
 
Source: O'Donnell, M. P. (2009). Definition of Health Promotion 2.0: Embracing 
Passion, Enhancing Motivation, Recognizing Dynamic Balance, and Creating 
Opportunities. American Journal of Health Promotion, 24(1), iv-iv. doi: 
10.4278/ajhp.24.1.iv 
  




O. Appendix O - Prevalence of diagnosed diabetes among individuals aged one year 












P. Appendix P - Chain of Accountability 
 
 
Source: Iqbal, S. (2017). Patient and Physician Views of Self-Testing 
  





Q. Appendix Q – ISO and CSA Standards 
 











ISO 15189:2012 — Medical laboratories -- 





ISO 15189:2012 specifies 
requirements for quality and 
competence in medical 
laboratories. 
 
ISO 15189:2012 can be used by 
medical laboratories in 
developing their quality 
management systems and 
assessing their own 
competence. It can also be used 
for confirming or recognizing the 
competence of medical 
laboratories by laboratory 
customers, regulating 
authorities, and accreditation 
bodies. 
ISO 22870:2006 — Point of care testing 







This standard is applied in conjunction with 
ISO 15189:2007 (Medical Laboratories -- 




ISO 22870:2006 gives specific 
requirements applicable to point 
of care testing and is intended to 
be used in conjunction with ISO 
15189. The requirements of this 
International Standard apply 
when POCT is carried out in 
hospital, clinic and by a health 
care organization providing 
ambulatory care. This 
International Standard can be 
applied to transcutaneous 
measurements, the analysis of 
expired air, and in vivo 
monitoring of physiological 
parameters. 
 
Patient self-testing in a home or 
community setting is excluded, 




Organization Relevant Laboratory Standard Description (From Source) 
but elements of this International 
Standard can be applicable. 
ISO 15197:2013 — In vitro diagnostic test 
systems -- Requirements for blood-
glucose monitoring systems for self-testing 




ISO 15197:2013 specifies 
requirements for in 
vitro glucose monitoring systems 
that 
measure glucose concentrations 
in capillary blood samples, for 
specific design verification 
procedures, and for the 
validation of performance by the 
intended users. These systems 
are intended for self-
measurement by lay persons for 
management of diabetes 
mellitus. 
ISO 15197:2013 is applicable to 
manufacturers of such systems 
and those other organizations 
(e.g. regulatory authorities and 
conformity assessment bodies) 
having the responsibility for 
assessing the performance of 
these systems. 
ISO 17593:2007 — Clinical laboratory 
testing and in vitro medical devices -- 
Requirements for in vitro monitoring 
systems for self-testing 





ISO 17593:2007 specifies 
requirements for in vitro 
measuring systems for self-
monitoring of vitamin 
K antagonist therapy, including 
performance, quality assurance, 
and user training and 
procedures for the verification 
and validation of performance by 
the intended users under actual 
and simulated conditions of use. 
ISO 17593:2007 pertains solely 
to prothrombin time-measuring 
systems used by individuals for 
monitoring their own vitamin 
K antagonist therapy, and which 
report results as international 




Organization Relevant Laboratory Standard Description (From Source) 
normalized ratios (INR). ISO 
17593:2007 is applicable to 
manufacturers of such systems 
and those other organizations 
(e.g., regulatory authorities and 
conformity assessment bodies) 
having the responsibility for 
assessing the performance of 
these systems. 
ISO/TS 22367:2008 — Medical laboratories 
-- Reduction of error through risk 






characterizes the application of 
ISO 15189 as a system for 
reducing laboratory error and 
improving patient safety by 
applying the principles of risk 
management, with reference to 
examination aspects — 
especially to pre- and post-
examination aspects — of the 
cycle of laboratory medical care. 
ISO/TS 22367:2008 proposes a 
methodology for finding and 
characterizing medical 
laboratory errors that would be 











CAN/CSA-Z22870-07 (R2013) - Point of 
Care Testing (POCT) - Requirements for 
Quality and Competence. (Adopted ISO 







specific requirements applicable 
to point-of-care testing and is 
intended to be used in 
conjunction with ISO 15189. The 
requirements of this 
International Standard apply 
when POCT is carried out in 
hospital, clinic and by a health 
care organization providing 
ambulatory care. This 
International Standard can be 
applied to transcutaneous 
measurements, the analysis of 
expired air, and in vivo 




Organization Relevant Laboratory Standard Description (From Source) 
monitoring of physiological 
parameters. 
 
Patient self-testing in a home or 
community setting is excluded, 
but elements of this International 
Standard can be applicable. 
CAN/CSA-Z902-10 -





CAN/CSA-Z902-10 is intended 
to ensure that the critical 
elements and methods 
of blood safety, efficacy, and 
quality are incorporated into 
facility procedures. 
Source: Canadian Agency for Drugs and Technologies in Health (CADTH). (2014).  Point-of-Care Testing 
of International Normalized Ratio for Patients on Oral Anticoagulant Therapy: Systematic Review and 












Source: Farrance, I. (2012). Review: Policies, procedures and guidelines for point-of-care 
testing.  Australasian Association of Clinical Biochemists. Retrieved from 
https://www.aacb.asn.au/documents/item/635 
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